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Abstract 
This thesis uses critical discourse analysis (CDA) to explore and examine direct-to-
consumer (DTC) pharmaceutical drug advertisements appearing in four issues of 0, The 
Oprah Magazine in 2006. The theoretical underpinnings of this thesis emerge from social 
scientists and feminists analyses regarding the medicalization of everyday life. The 
findings of this study highlight three types of discourses used by pharmaceutical 
companies. First, I explore the use of historical and contemporary gender norms to sell 
pharmacological products; second, I examine discourses which normalize the use of 
chemical solutions as the first line of defense to address a wide range of everyday 
problems; and finally, I assess how pharmaceutical advertisements provide an illusion of 
autonomy by responsibilizing individuals as patients, at the same time as they suggest 
that real independence can only be achieved with medication. My discussion of these 
themes also includes an analysis of why 0 Magazine, which explicitly promotes 
women's empowerment through holistic approaches to health and personal growth-
might support such advertising. Thus I explore: how does DTC advertising benefit both 
pharmaceutical companies and 0 Magazine itself? I conclude through a brief discussion 
of the larger implications ofDTC advertising for women's health. 
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CHAPTER ONE: INTRODUCTION 
Statement 0/ Research 
This qualitative study is designed to explore and examine the discourses in 
pharmaceutical drug advertisements appearing in four issues of 0, The Oprah Magazine 
in 2006. The theoretical underpinning of this thesis is based on the concerns of social 
scientists regarding the contemporary medicalization of everyday life. More specifically, 
this project employs feminist critiques of the gendered nature of medicalization to argue 
that direct-to-consumer prescription drug ads in 0 Magazine reiterate and reinforce 
discourses of traditional gender identity, normality and autonomy. I use critical discourse 
analysis, a qualitative methodology, to facilitate understanding of the phenomenon, and 
to explore how these advertisements work in the context of Oprah Winfrey's magazine, 
O. 
An Ad/or Depression 
A woman, forlorn and alone at her desk, is "still caught in the cycle of 
depression" (see Figure A.I). The woman's left hand is propping her head up; she 
appears to be unable to concentrate on her work. Readers are told by the woman that "my 
symptoms of depression won't go away (sadness, anxiety, low energy)" and "1 keep 
falling into depression no matter what I do." The second page ofthe advertisement tells a 
very different story. The woman is now shown smiling and the caption reads "break the 
cycle with EFFEXOR XR". Wyeth (the pharmaceutical company responsible for the ad) 
would likely claim this advertisement is meant to educate women about depression, but 
perhaps what is really being marketed here is the condition itself. If readers can be 
convinced they have a treatable "illness" called depression, this makes it much easier for 
the company to sell its drug Effexor. Although genuine depression is generally 
understood as an illness that takes away people's ability to function in daily activities, 
Effexor XR in this ad is presented as the answer for the sadness, anxiety and low energy 
that can also be associated with daily life (Moynihan & Cassels, 2005, p. 40). Medication 
is the only solution presented for this woman's depressive symptoms. This ad from the 
April 2006 issue of 0, The Oprah Magazine is demonstrative of the ways in which illness 
is constructed through discourses in pharmaceutical advertisements as an individual 
problem that can be cured by using a chemical solution. The ad also presents a gendered 
discourse; this ad is targeted at women specifically. As Ann Garry notes: "although all 
people are subject to medicalizing practices, medicalization is a feminist issue because 
women, along with other marginalized people, are particularly disadvantaged by it" 
(Garry, 2001, pp. 263-264). A more in-depth analysis of the discourses in this 
advertisement and others found in 0 Magazine will be discussed throughout this thesis. 
Why I chose this topic: Auto-ethnography 
My passion for this topic is driven not only by academic interest, but also by 
personal experiences. I begin my exploration of the intricacies of the medicalization 
process by sharing three stories. The first two stories introduce the experiences of two 
men with the medicalization process. The third story is an auto-ethnographic account of 
my own personal experience with medicalization. Auto-ethnography, according to 
Carolyn Ellis, "refers to writing about the personal and its relationship to culture" (2004, 
p. 37). More specifically, auto-ethnography is a form of qualitative inquiry which allows 
the use of systematic sociological introspection and emotional recall; the inclusion 
of the researchers' vulnerable selves, emotions, body, and spirit; the production of 
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evocative stories that create the effect of reality; the celebration of concrete 
experience and intimate detail; the examination of how human experience is 
endowed with meaning (Sparkes, in Bochner & Ellis, 2002, p. 210). 
Deborah Reed-Danahay notes "the notion of auto-ethnography foregrounds the multiple 
nature of selfhood and opens up new ways of writing about social life" (1997, p. 3). I 
chose to write an auto-ethnographic introduction because constructing meaningful 
accounts of emotional experiences is said to allow humans to make sense of their worlds 
(Ellis, 2004). I want to better understand myself and my personal experiences with 
medicalization, in relation to this research. Ellis argues it is "self-absorbed to pretend that 
you are somehow outside of what you study and not impacted by the same forces as 
others" (2004, p. 34). Moreover Ellis and Bochner note, as communicating humans 
studying human communication, we are inevitably inside of what we are studying (2002). 
I felt that my relationship with medicalization needed some reflexive thought. 
Furthermore, although auto-ethnographic writing can benefit the author, it can also be 
used to "allow readers to think and feel with the story being told rather than about it" 
(Sparkes, in Bochner & Ellis, 2002, p. 219). 
Until a close friend was diagnosed with depression, I was unaware of the extent of 
medicalization and the pharmaceutical industry' s role in it. I was in my early twenties and 
about mid-way through my undergraduate degree when a close male friend told me he 
was given depression medication by his doctor. I was critical of this diagnosis because I 
was familiar with my friend's circumstances; he had suddenly found himself unemployed 
and his mother had recently been diagnosed with cancer. When I first heard about this 
diagnosis, I remember thinking his "symptoms" of disturbed sleep, decreased energy and 
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agitation were normal reactions to the external changes he found himself dealing with. 
Frustrated and upset about the ease of this diagnosis, I found myself driven to understand 
more about this process. 
In my third year of undergraduate studies, I took a Psychiatric Sociology course 
which made me determined to find out more about the influence the pharmaceutical 
industry has over people's health. For my undergraduate thesis I sought to explore and 
examine the lives, challenges and experiences of adults who had been diagnosed with 
ADHD either as children or at some other point in their lives. During this research I 
spoke to one young man who was diagnosed with ADHD through Health Services at the 
university. This particular case caught my interest because of the relatively simplistic 
diagnostic process he went through. 
I don't think I was tested right enough, you know? Like just. .. one hour or two 
hours of just sitting in front of somebody and [she just says] "Ok, you have 
it" . . . the whole process [including paper work] took two hours. And I had to come 
back two weeks later .. . for another hour ... but, that's about it. So 1 don't know ... 1 
don't know how else they could test for it, but there's got to be something better 
than just a two-hour thing you know? Because ... the interview was at lpm and 
then I got the pills at 5pm. So .. .4 hours later I have ADD and I have the pills 
right? And I got them in my hand and I'm [thinking] "That was just too easy." 
Anyone could just lie on that test thing (Williams, 2005). 
Similar to my friend's experience with depression, this student was also dealing with 
external challenges. At the time of the interview, he was in his third year of university 
and talked about needing to get his average back up to 70% by fourth year. If he did not 
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achieve this goal, his program would not recognize his marketing concentration. The 
possibility of being unable to raise his marks was very stressful for him. He also 
mentioned that you could lie on the test for ADHD if you wanted medication for a 
particular reason such as assistance with studying.' Consequently, I began to question 
whether the diagnostic process was scientifically reliable and to wonder whether it 
encouraged a thorough analysis of the patient's life circumstances. 
At the conclusion of my undergraduate thesis, I sought to expand this study on 
ADHD and focus more directly on the pharmaceutical industry's role in the 
medicalization of everyday life for my Master's thesis. I was both upset and excited about 
the considerable confusion and debate surrounding the diagnostic process and various 
"new" illnesses. 
As my current Master's thesis progressed, I suddenly found myself facing a 
variety of difficult and sometimes traumatic external challenges. Like my male 
counterparts, I struggled to find a way to map out, clearly articulate and decide on an 
appropriate solution to my life issues. During this research project, I encountered some 
unexpected and painful experiences. I say unexpected because I was engaged in what I 
envisaged to be a purposeful and objective research process. Painful because along the 
way I encountered many obstacles that made me give up my "safe" distance from 
medicalization within my research and embrace a less predictable approach. I suddenly 
found myself within my research, rather than standing outside of it and maintaining 
control over it. I was experiencing the complex concepts and processes I was studying. 
I There is a fine line between medical and recreational drug use for ADHD medication. See Williams, 
2005, p. 43. 
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After dealing with many personal and professional struggles on my own, I 
decided to try counseling through Student Health Services at the university to relieve 
some stress. Like the male participant in my undergraduate thesis, I received a 
questionnaire administered by the university ' s Health Services office. Upon my first 
visit, the counselor said I had to complete two questionnaires; one was a test for anxiety 
and the other was for depression. The counselor proceeded to ask me questions as I either 
"agreed" or "disagreed" with the symptoms described. Afterwards, my score was added 
up and it appeared I was suffering from severe anxiety coupled with mild depression. I 
was then told I had to see my doctor to rule out any chemical imbalance before I could 
see the counselor again. I questioned why the counseling service prioritized 
pharmaceutical intervention before being willing to talk to me about the life challenges 
that might be causing my symptoms. Could the feelings I was experiencing be measured 
by a five-minute questionnaire? How could I be told I may have severe anxiety and mild 
depression by someone who did not even know who I was or the stressful life 
circumstances I was grappling with? 
When I saw my doctor, I explained that I wanted to try counseling before 
considering medication as the first option. My doctor agreed and signed the 
questionnaires so I was able to see the counselor again (without medication) and I 
continued going regularly. Other people I confided in during this time also suggested I 
should maybe look into medication. These encounters forced me to engage with the 
medicalization process on a personal rather than an academic level. This made me want 
to explore why mind-altering medication is considered central in the treatment of 
emotions. 
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Confused and disappointed, J wrestled with competing thoughts. On the one 
hand, I acknowledged that I was anxious and felt somewhat depressed and might, 
therefore, need to consider taking medication. However, my critical faculties reminded 
me that I was encountering several external challenges. I remember thinking that anyone 
in my position would also feel anxious, unhappy and have low energy. I began to wonder 
if what I was feeling was ' normal. ' After much thought, I decided to consider other non-
chemical solutions first. I continued going to counseling regularly, joined an eight-week 
beginner' s yoga class and began attending Church. Talking about my struggles, 
exercising and reconnecting with my body and with God really helped me through these 
difficult times. 
Taking into consideration my own experiences over the years as well as those of 
my friends, I had begun to question current diagnostic practices. Why are people who 
experience external problems being treated first with psychotropic drugs? While I found 
my personal circumstances and quick diagnosis similar to my male counterparts, more 
women than men walk through the doors of doctors ' and counselors' offices seeking help 
for emotional trauma, so they are more exposed to pharmacological and medicalization 
discourses which promote the need for medication. Also, more pharmaceutical companies 
advertise their products directly to women, further intensifying the gendered nature of 
medicalization (Penfold & Walker, 1983). 
After starting to think critically about these issues, I received a subscription to 0 , 
The Oprah Magazine as a gift during the first year of my Master's program. I've always 
admired Oprah Winfrey and I knew she was focused on helping people live their best life, 
thus, I was surprised to find pharmaceutical drug advertisements throughout all of the 
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issues I received that year. For my Master's thesis, I decided to explore the messages 
these pharmaceutical drug advertisements strive to communicate to readers about the 
medicalization of everyday life and what it means that such an influential magazine 
apparently committed to promoting personal growth for women is publishing these ads. 
Statement of the Problem 
Well-informed, well-educated human beings can make sound decisions in 
the interests of the common good, but they will not be able to do so if their 
minds are crammed with misinformation, half truths, and the downright 
lies which are passed off as "common knowledge" (Judith Blackwell, 
2003, p. 23) 
In a free-market economy, consumers are supposed to be informed and have free 
choice about their consumer purchases, but these expectations are often more difficult 
when it comes to the medical market (Conrad & Leiter, 2004, p. 160). Over the last few 
decades, the pharmaceutical industry has been criticized for targeting consumers directly 
through direct-to-consumer (DTC) drug advertisements. Of even more concern to social 
researchers, however, is the fact that pharmaceutical companies have changed their 
tactics from a focus on the sick, to targeting the well and healthy (Moynihan & Cassels, 
2005). While pharmaceutical industry supporters claim that DTC advertising responds to 
the consumer's right to information and need for information about prescription drugs, 
critics are concerned that such advertising can lead to unnecessary use of medication and 
excessive profits for drug companies. Furthermore, David Gardner, Barbara Mintzes and 
Aleck Ostry argue there is a lack of evidence to support pharmaceutical companies' 
claims about educating the public (2003, p. 426). Those opposed to DTC advertising 
specifically and critical of the pharmaceutical industry in general say that the public's 
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health is at risk. Further, feminist scholars argue that pharmaceutical practices are 
motivated by, and contribute to, the attribution of illness specifically to women. For 
instance, Susan Penfold and Gillian Walker note drug advertising "plays a major role in 
reinforcing stereotypes and encouraging the administration of drugs to women" (1983 , p. 
198). This thesis seeks to better understand discourses found in pharmaceutical drug 
advertisements in 0 Magazine specifically and how they relate to the medicalization of 
everyday life. 
According to Justine Coupland and Angie Williams, advertisements are one of the 
resources used by the public to make decisions about health and lifestyle (2002, p. 421). 
In this context, discourse refers to "the full range of practices, structures, and media that 
saturate our world and ourselves with meaning" and therefore contribute to how 
knowledge is constructed and produced through social relations (Carroll, 2004, p. 225). 
Critical discourse analysis is a type of qualitative research that can facilitate meaningful 
understandings about texts. Analyzing direct-to-consumer drug advertisements using this 
critical methodology can allow a greater understanding of the gendered discourses around 
health, illness and healing that are communicated through the ads. A discursive reading of 
the ads can explore how pharmaceutical advertising discourses in 0 Magazine employ 
Oprah Winfrey 'S ' brand' to endorse the current trend towards the medicalization of 
everyday life. 
Overview of Chapters 
The thesis unfolds as follows. Chapter Two explores the history, meaning and 
effects of medicalization as well as the institutional and professional structure of the 
pharmaceutical industry, which contribute to the public' s assumptions about the 
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prevalence, incidence, treatment, and meaning of disease. I situate my work in relation to 
the current literature on the gendered nature of medicalization. The contribution of my 
study is to better understand the potential impact of DTC ads in an influential women' s 
magazine on women' s experience of health and illness. 
Chapter Three offers background information on critical discourse analysis 
(CDA), a method of qualitative research that I have used to perform a close systematic 
analysis of discourses found in pharmaceutical drug advertisements in 0 Magazine . 
Critically analyzing direct-to-consumer drug advertisements can allow a greater 
understanding of how social forces can shape our actions in the realm of health, illness 
and healing. In addition to discussing the role of discourse in shaping knowledge, I 
explore the effects of institutional and professional structures which also produce 
assumptions about the prevalence, incidence, treatment, and meaning of disease. I explain 
my methodological choices and constraints in conducting this qualitative research project, 
and discuss the source and sample used for analysis. 
Chapter Four presents the findings of the research. I begin with a background on 
advertising strategies in order to acquaint the reader with common marketing techniques 
used by companies to sell their products. I then present an exploration of 21 direct-to-
consumer prescription drug advertisements in 0 Magazine, and highlight three types of 
discourses used by pharmaceutical companies. First, I explore the use of historical and 
contemporary gender norms to sell pharmacological products; second, I examine 
discourses which normalize the use of chemical solutions as the first line of defense to 
address a wide range of everyday problems; and finally, I assess how pharmaceutical 
advertisements provide an illusion oj autonomy by responsibilizing individuals as 
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patients, at the same time as they suggests that real independence can only be achieved 
with medication. 
Chapter Five discusses the larger implications of the discourses found in Chapter 
Four. I highlight a discussion on Oprah Winfrey's power and influence as a self help icon 
and explore the intersection of 'brand 0' with pharmaceutical advertising. I then discuss 
the illusion of autonomy found in the advertisements. Next, I explore the problems of 
discourse as power. I then show how an analysis of pharmaceutical drugs advertisements 
in 0, The Oprah Magazine contributes to the broader analysis of the medicalization of 
everyday life. This chapter ends with a summary of the main points of this thesis. 
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CHAPTER TWO: THE CONTEXT OF THE RESEARCH, A 
LITERATURE REVIEW 
Discourses around health, illness and medication permeate a variety of texts from 
mass media to everyday conversations. Sales pitches for pharmaceutical drugs in 
particular generally feature "beautiful [happy] people enjoying themselves in the great 
outdoors" as a result of taking a particular medication (Angell, 2004, p. xix). In this 
context, celebrities have become central figures in drug company campaigns. For 
example, Ray Moynihan and Alan Cassels explain that "baseball stars help transform 
fears about sexual performance into pills for sexual dysfunction" and former super 
models help sell menopause as a fearful time of hormone loss rather than a natural life 
process (2005, p. 42). These types of media presentations tend to favour genetic or 
biological explanations for illness over social causes in order to promote the use of 
medication. Pharmaceutical companies claim that their advertisements educate the public, 
but money for such 'education' "comes out of the drug companies' marketing budgets" 
which is a clear indicator that the goal here is marketing, not education (Angell, 2004, p. 
135). Although people select and interpret information from various sources, researchers 
have argued that the massive pharmaceutical marketing the public sees everyday in the 
media keeps a biomedical discourse dominant. Thus, public perceptions can reflect a 
partial and inevitably biased perspective of the role biological factors play in life's 
problems. 
This literature review examines what research has told us in three main areas. The 
first looks at what medicalization is and how it came about in order to create a better 
understanding of the structural power behind medicine. Also in this section, the gendered 
nature of medicalization is explored in order to understand how and why women are 
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specific targets of medicalization. Secondly, I explore the pharmaceutical industry and 
the ways in which it has facilitated medicalization into the 21 sl century. Lastly, this 
chapter focuses on the most recent trend in medicalization, direct-to-consumer drug 
advertising. 
Medicalization: The History 
Concern over medical influence or medicalization is not new. The actual term 
"medicalization" began appearing in social scientific literature in the 1970s (Conrad, 
1992, p. 210), while the idea behind the concept has been present since Talcott Parsons 
introduced it (1951). According to Peter Conrad, Parsons was "the first to conceptualize 
medicine as an institution of social control, especially the way in which the 'sick role' 
could conditionally legitimate that deviance termed illness" (1992, p. 210). Ivan Illich 
(1976) was also an early influential critic of medicine, coining the phrase "the 
medicalization of life." Eliot Freidson (1975) and Irving Kenneth Zola (1977) are two of 
the initial examiners of medicalization and medical social control while Conrad has 
focused most of his studies on the medicalization of deviant behavior, when bad 
behaviour becomes labeled as sickness (1992). Moreover, Michel Foucault also criticized 
this trend toward the medicalization of human behaviour and the power of medical 
"experts" (see for example The Birth of the Clinic (1973) and Madness and Civilization 
(2001)). 
Most of the writers on medicalization would agree that the term pertains to the 
influence of medicine, and how medical professionals and/or pharmaceutical companies 
continue to push medication - causing humans to seek more medical attention and advice. 
Zola, for example, provides a straightforward definition of medicalization: "making 
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medicine and the labels 'healthy' and ' ill ' relevant to an ever increasing part of human 
existence" (1977, p. 42). Rick Carlson and Gary Stimeling put more emphasis on the 
influence of the medical profession, arguing "[ m ]edicalization happens when physicians 
claim more aspects of human life as their turf, turning commonplace conditions into 
' diseases' that can be cured only by medicine" (2002, p. 51). Sociologists and feminists 
in particular have contributed to the understanding of medicalization by examining a 
wider and different range of social issues than have other medical researchers. According 
to feminist perspectives, medicalization "refers to the tendency to exert medical control 
over normal female reproductive experiences, to apply medical definitions to bodily 
occurrences not previously thought of as medical problems, and to treat normal bodily 
functions using an overly aggressive approach" (Richman, Jason, Taylor & Jahn, 2000, 
p.177). In other words, feminists argue that medicalization contributes to the maintenance 
of gender inequality and directly impacts women's health and well-being (Penfold & 
Walker, 1983; Caplan, 1995). 
As these definitions suggest, the general conceptualization of medicalization has 
remained relatively unchanged over the past three decades. However, opinions and 
evidence have differed around the "medicalization process," or how medicalization 
actually occurs (Conrad, 1992, p. 210). 
Medicalization: Examples and Contributing Factors 
Although the definition of medicalization is broad enough to include all problems 
that come to be defined as medical, the actual process of medicalization is much more 
complex. For instance, Conrad notes: "subcultures, groups, or individuals may vary in 
their readiness to apply, accept or reject medicalized definitions" (1992, p. 211). These 
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and other economic, social or cultural factors can affect the expansive potential of a 
medical category (what Conrad refers to as the "degree" of medicalization) (Conrad, 
1992, p. 220), or how a problem, behaviour or emotion comes to be defined or undefined 
as a medical condition. 
Adding to Conrad's argument, Phil Brown discusses how social forces cause and 
exacerbate disease (1995). Brown helps identify the range of social actors involved in the 
medicalization process. Brown notes that the social changes surrounding a condition can 
move it from being considered non-medicalized to medicalized or vice versa. Two cases 
illustrate both processes. First, the history of homosexuality provides an example of how 
a medicalized condition can become demedicalized. Homosexuality was once considered 
a medicalized psychiatric illness in the Diagnostic and Statistics Manual of Mental 
Disorders III (DSM III) (APA, 1980).2 Over time, a definitional shift occurred, as social 
activists put political pressure on the American Psychiatric Association to delete 
homosexuality as a mental disorder (Brown, 1995, p. 43). Today, homosexuality is no 
longer a medical category (see DSM-IV) (APA, 1996). Second, Attention-deficit 
Hyperactivity Disorder is an example of a non-medicalized behaviour becoming 
medicalized. Restless children who do not listen to their parents or teachers, have trouble 
focusing and continually misbehave have not always been classified as having a 
behavioural disorder. This behaviour has become medicalized over the last half-century 
and Attention-deficit Hyperactivity Disorder (ADHD) is now one of the most common 
psychiatric conditions to appear in children in North America (Degrandpre, 1999, p. 33). 
2 Although this was not always the case. See Hansen, Bert. "American Physicians' "Discovery" of 
Homosexuals, 1880-1900: A new diagnosis in a changing society" in Charles E. Rosenberg and Janet L. 
Golden, eds., Framing Disease: Studies in Cultural History (1992) 
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Social science researchers have argued that the medicalization of ADHD has occurred 
because of several social and economic factors (see DeGrandpre, 1999; Conrad, 1992). 
For instance, treatment options such as Ritalin were introduced in the 1950s and soon 
became widely available for children suffering from hyperactivity and inattention 
(Beiderman, Quinn, Weiss, Markabi, Weidenmann, Edson, Karlsson, Pohlmann, & 
Wigal, 2003 , p. 833). At this time, psychiatrists were also becoming persistent in their 
drive towards a biomedical explanation for ADHD (DeGrandpre, 1999, p. 149). 
Moreover, increased preference for medical solutions along with parents' and teachers' 
desire for answers to children's misbehaviours are significant reasons why ADHD has 
become an epidemic in North America (Conrad & Schneider, 1992; Armstrong, 1997; 
DeGrandpre, 1999). 
Yet, such dichotomies may blur the subtle variations in medicalized definitions. 
Instead of thinking of medicalization as an "either/or situation" where some conditions or 
illnesses are non-medical while others are inarguably medical in nature, Conrad argues 
that medicalization is best discussed as occurring by degrees (1992, p. 220). In other 
words, not all diagnoses will fit neatly into a single medicalized or non-medicalized 
category, but instead remain open to both medical and non-medical definitions. Female 
Sexual Dysfunction or FSD for example has fairly recently been classified as a disease 
said to "affect 43 per cent of women" (Moynihan & Cassels, 2005 , p. 175), although 
evidence suggests that there is still much debate among researchers and the medical 
profession surrounding the actual medical definition ofFSD. Besides issues of competing 
definitions, lack of medical support seems to be inhibiting the full medicalization process 
or expansive potential ofFSD. According to Moynihan and Cassels, "some researchers 
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were rejecting the notion that there was a medical condition" regarding female sexual 
problems (2005, p. 176). This is a case where the condition is not accepted by everyone 
as a medicalized condition, yet a biomedical definition is applied. 3 
While there is an abundance of literature on the social and economic factors 
affecting the expansive potential of various medicalized conditions, there are also many 
other issues that can shape disease definitions to restrain or accelerate such a process. 
Examples include patient advocacy groups or social movement organizations and one's 
personal experience with illness (see Brown, 1995, p. 49). With relatively few limiting 
factors , however, medicalization or the expansion of medical jurisdiction over what is 
considered sickness appears to be on the rise. 
Medicalization and Power 
A brief examination of the history of medicine can demonstrate the links between 
medical definitions and power. During the seventeenth and eighteenth centuries, religion 
defined what normal , proper and desirable behaviour was in Western society. The 
Industrial Revolution, however, began altering "the relationship within and between 
communities, families and people" and new explanations for behaviour were sought 
(Zola, 1977, p. 44). Religious ideologies began to appear irrational as they lacked broad 
social acceptance and scientific validity (Freund & McGuire, 1999, p. 126). Legal 
systems began to define norms of behaviour by classifying certain behaviours as crimes 
with specified punitive consequences. Religion did not disappear, but concerned itself 
more with providing internal guidance, leaving the external affairs to the law (Zola, 1977, 
p. 45). Legal definitions, although they appeared more rational, were often criticized for 
3 The medicalization process also involves the ways in which "nonconflictual" diseases are discovered 
and/or defined. See Phil Brown, 1995, pA3 
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being too dependent on moral judgment. Major transformations in the twentieth century 
introduced doubts about legal authority. As scientific theories began to re-shape the 
contours of modern society (Zola, 1977, p. 46; Conrad & Schnieder, 1992, p. 262), 
human behaviour began to be explained in medical terms (Conrad & Sclmeider, 1992, p. 
263). Medical definitions, as opposed to rel igious and legal explanations, were based on 
supposedly objective criteria rather than human judgment, and the public seemed to have 
more faith in this type of "rational" scientific ideology. 
After the Second World War, when public expectations for a better life and 
political pressure on government to supply it grew, so did "the human services" sector in 
Western societies (Freidson, 1975, p. 3). For instance, although new definitions of 
citizens' rights to health, education, legal and welfare services were advanced, Freidson 
states that some of the most critical changes took place in health services (1975 , p. 4). 
Progress in modern medicine and health became an essential element to living "the good 
life" (Zola, 1977, p. 51; also see Tone, 2009), thereby increasing the role of physicians, 
who were the gatekeepers and providers of these services. Some would argue that today, 
countless advances in medical technology, surgical procedures and life-altering 
medication are nothing short of miracles which have immensely transformed our quality 
of life as well as the society we live in. Increasingly, people believe that the capabilities 
of scientific research are boundless. 
With the industrialization and bureaucratization of society, governments, 
education systems, and the medical sphere began to develop more capacity for social 
control. According to Conrad and Schneider, medical social control or "the acceptance of 
a medical perspective as the dominant definition of certain phenomena" is one of the 
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most powerful forms of control (1992, p. 242). The degree to which people find 
themselves affected by other people ' s opinions of what is normal , Paula Caplan argues, 
depends on "how much power they have over us, how much we care about them, how 
much we respect their opinion, how normal we consider them to be and how insecure we 
are" (Caplan, 1995, p. 5-6). Foucault contends that medical social control conflicts with 
autonomous personal decision-making because there is a relationship between knowledge 
claims, the power of people making those knowledge claims, and the resulting influence 
those knowledge claims have (1980, p. 93-94). Thus, when claims to "truth" come from 
individuals or groups in society with high levels of institutionalized power (as in the 
medical profession), those claims also become institutionalized; people believe those 
claims simply because they are coming from "experts." 
According to Freidson, the unprecedented power of physicians over the medical 
field, the medical institution and medical practitioners within it allows them to define the 
territory of their work (Freidson, 1975). Much of Friedson' s work seeks to explore and 
problematize the power that the medical profession has over the labels "health" and 
"illness" (1975; 1986). Thus, Friedson warns that physicians and their allied institutions 
often make rules that are compatible with their own conceptions of "need, propriety, and 
convenience" instead of looking out for the greater good of society (1975, p . 14). 
Promoting the use of medications essentially supports the existing social and political 
arrangement whereby individualized solutions are presented for "individual disease rather 
than a possible comment on the nature of the present situation," thus inhibiting change to 
the dominant social and political interests (Conrad & Schneider, 1992, p. 250). More 
importantly for Illich, however, professional power can "destroy the potential of people 
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to deal with their human weakness, vulnerability, and uniqueness in a personal and 
autonomous way" (Illich, 1976, p. 33). While medical social control limits or is 
sometimes in conflict with autonomous patient decision-making, we also know that the 
process of how people are influenced by medical power is complex and not necessarily 
predictable. 
Public faith in the work of doctors, researchers, and other "experts" in the field 
has been questioned by many social researchers. Carlson and Stimeling, for example, 
warn against ignoring the distinction between the reputation and the reality of modern 
medicine. While there is no doubt that many medical breakthroughs hold great promise 
for the future, 
medical advances are coming at us so quickly that we are groping for context, a 
framework in which to think clearly, as responsible citizens of the earth, about 
the pros and cons of our new powers before we're swept away by them (Carlson 
& Stimeling, 2002, p. 6). 
The growth of pharmaceuticals, for example, can reduce efforts to find other non-
chemical solutions and make pharmaceuticals a panacea. Since the 1950s there has been 
an explosion in both the development and use of psychoactive medication for problems 
within the mind and body (Conrad & Schneider, 1992, p. 243). Drugs have been invented 
and distributed in abundance for many behaviours including but not limited to: anxiety, 
nervousness, general malaise, hyperactive children, and gender dysphoria. Again, when 
medication is the first and often only solution to problems, it locates the source of 
problems within the individual instead of looking at the social, economic and political 
system (Zola, 1977, p. 63). For example, many pharmaceutical companies have helped 
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instill and reinforce the notion that depression is a widespread psychiatric disease "most 
likely due to a chemical imbalance in the brain, best fixed with a modern group of drugs 
called selective serotonin reuptake inhibitors or SSRls" (Moynihan & Cassels, 2005, p. 
23). Focusing on depression as a psychiatric illness treatable with mind-altering 
medication, however, ignores the possibility that the behaviour is not an illness, but an 
"adaptation to the social situation" (Conrad & Schneider, 1992, p. 250). Medical control 
through medication ignores issues within the social system and may inhibit people ' s 
ability to explore non-medical solutions to life ' s difficulties. 
The Gendered Nature of Medicalization 
According to feminist researchers, medicalization has affected men and women in 
different ways. For instance, Catharine Reissman argues women are "more likely than 
men to have problematic experiences defined and treated medically" (1983 , p. 49). 
Concerning prescribing patterns and gender, Ruth Cooperstock reports that "women are 2 
to 3 times more likely than men to have prescriptions written" for psychotropic 
medication (1974, p. 56), while Penfold and Walker report "women receive more 
prescriptions for all drugs than do men" (1983, p. 186). For psychotropic drugs, however, 
the female to male ratio is even higher, with "67-72% of prescriptions going to women" 
(Penfold & Walker, 1983, p.186). Karen Erikson and Victoria Kress, who studied the 
prevalence of diagnosis by gender with respect to biases made according to the DSM, 
contend this gender difference in pill popping is because "women's prevalence rates . . . for 
all forms of mood and anxiety and eating disorders" were higher than men's (2008, p. 
153). Betty Friedan argues that breakdowns and emotional distress should be attributed to 
what she calls the "role crisis," or women trying to fulfill their feminine destiny (1974, p. 
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75). While these statistics show women are diagnosed and prescribed medication more 
often than men, the pharmaceutical industry has also intervened to construct non-medical 
conditions, such as aging, as ' problems' which require a pharmaceutical or surgical 
solution. Thus, advertisements have "used familiar biomedical phraseology to turn the 
effects of aging - loose and sagging skin, wrinkles and creases - into pathology" 
(Ratcliff, 2002, p. 133). 
While it is clear there are gender biases in society which intersect with the 
medicalization process, it has been important for feminists to understand why this 
difference takes place. Penfold and Walker suggest medicalization is gendered because 
"women are more ready to label themselves as psychiatrically ill" (1983, p. 190). 
Reissman contends that women's social roles make them readily available to medical 
scrutiny as, "women are more likely to come in contact with medical providers because 
they care for children and are the 'kin keepers' of the family" (1983 , p. 58). In other 
words, women make more visits to physicians than men for children and other family 
members and thus are more exposed to the medical process (Reissman, 1983; Ratcliff, 
2002). Reissman also argues that women are targets of medicalization because "external 
markers of biological processes exist in women (menstruation, birth, lactation and so 
forth) . .. [making] women easy targets for medical encroachment" (1983, p. 58). Erikson 
and Kress report numerous environmental factors said to account for "the high rates of 
depression and other disorders in women" including lack of social support networks, 
being married or separated/divorced, single motherhood etc. (2008, p. 156). 
While some feminists feel that women's biology and social roles make them more 
susceptible to the medicalization process, other feminists feel that the influence of 
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medicalization has been exaggerated. Jeanne Lorentzen argues that women are not 
passive recipients of medical care and medicalization but rather are active participants in 
medical power relations (2008, p. 52). Janet Walker, who focused on analyzing 
psychiatry and American cinema and its relation to the medicalization of women, notes 
"the discursive practices and formations around psychiatry, women, and film couched 
resistance as well as adjustment" (emphasis in original, 1993, p. xvii). By the term 
resistance, Walker means "to characterize various ways psychiatrists, patients, and people 
concerned with the representation thereof sought to rethink ideas, actions, and live at 
odds with a status quo according to which institutional psychiatry dictated normative and 
gender-allocated behavioral patterns" (1993, p. xviii). According to Lorentzen, who takes 
a Foucauldian approach to medical power relations, "the outcome of medical power 
relations cannot be conceived as predetermined, that is, as only producing passive 
compliant bodies" (2008, p. 56). Similarly, Riessman contends "women are not simply 
passive victims of medical ascendancy" (1983, p. 47). These feminist authors show that 
although medical ideologies are dominant, not all women are necessarily influenced by 
this. 
While individual women often resist the medicalization process, the systems of 
medical power have a long history of attempting to control women's lives. For example, 
most concepts of mental health are male defined and psychiatric, psychological and 
biological theories reflect and reinforce the existing power relations in a way that 
continue to oppress women. Barbara Ehrenreich and Deirdre English, who studied 
medical practices from the late nineteenth century to the early twentieth century note that 
doctors defined women's normal state as sick (2005, p. 121). Walker argues that drugs 
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were used as "adjustment treatments" to keep women comfortable in their traditional 
gender roles (1993 , p. 29). Penfold and Walker also argue that drugs are being 
administered according to socially determined notions of sex roles: "drugs are often 
presented as the solution for women ' s problems, to help them cope with their traditional 
[gender] roles" (1983, p. 198). The medicalization of women "appears to be rooted in the 
unrecognized stresses of women ' s traditional role and the pervasive sentiment that 
women who deviate from , or complain about, their traditional role as wife, mother and 
sex object and self-sacrificing nurturer must be sick" (Penfold & Walker, 1983, p. 196). 
Meanwhile, adjustment to a "suffocating atmosphere of domesticity," according to 
Ehrenreich and English is what lead women to sickness in the first place (2005, p. 118). 
When drugs are administered according to socially determined notions of gender, the 
difficult and distressing life circumstances of women can be more easily disregarded. 
Friedan notes "adjustment to a culture which does not permit the realization of one ' s 
entire being is not a cure at all" (1974, p. 311). For Friedan, normal feminine adjustment 
is the failure to realize the full possibilities of one ' s existence (1974, p. 312). Feminine 
adjustment makes women dependent on "technological cure rather than self-directed 
analysis or change" (Walker, 1993 , p. 29). 
Along with depoliticizing women ' s social position within a patriarchal society 
and individualizing social problems, the widespread use of medications is also dangerous. 
Simply put, some medicines have real, and often dangerous, side effects. An article in the 
Journal of the American Medical Association (lAMA) concluded "more than 2.2 million 
people required hospitalization because of serious reactions to medications" (Strand, 
2003 , p. 8). Many of these patients died because of these reactions. Moreover, the fourth 
24 
" . 
leading cause of death in the United States is not automobile accidents or AIDS but 
"adverse drug reactions to properly prescribed medications" (Strand, 2003, p. 8). This 
statistic does not include the number of deaths caused by medications that were 
prescribed improperly. As women are prescribed more drugs than men, this is particularly 
a problem for them. 
Many scholars have questioned the nature of the pharmaceutical business. 
Researchers have investigated how the pharmaceutical industry has grown to accumulate 
profound wealth and power and continues to enhance the cycle of "defining a problem in 
medical terms ... [and] using a medical intervention to treat it" (Conrad, 2005, p. 3). Thus, 
a review of the current literature on the pharmaceutical industry can enhance our 
understanding of medicalization. 
The Pharmaceutical Industry: Practices and History 
The modern pharmaceutical industry emerged with the new wave of "wonder 
drugs" that were discovered after World War Two. In the half-century before 1939, the 
pharmaceutical industry conducted itself as a commodity business: "the major companies 
were full-line drug houses that manufactured and sold a complete array of all the 
ingredients the pharmacist needed to compound the doctor's prescription" (Gereffi, 1983, 
p. 169). At this time therapeutic advancement was slow and drug companies engaged in 
very little research. By the end of the 1950s however, the pharmaceutical industry had 
transformed itself into a research and advertising-intensive business. The drug industry 
grew rapidly with new medical and scientific advancements and began to focus on 
producing specialty products whose value could be protected by patents and heavily 
promoted brand names (Gereffi, 1983, p. 169). 
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During this period of spectacular growth, the pharmaceutical industry's increasing 
influence on the research community has sometimes been troubling. One of the most 
well- documented examples is the Nancy Olivieri case. As one of Toronto's Hospital for 
Sick Children's top researchers, and a clinician at the University of Toronto, Dr. Nancy 
Olivieri was passionate about making drug therapy available to the public. Her specific 
focus throughout the 1990s was on studying the drug deferiprone, which needed to be 
tested on children in drug trials to see if it could help with the inherited blood disorder, 
thalassemia (Olivieri, 2003, p. 32). In 1995 Olivieri and her colleagues found that "liver 
biopsies in some of the Toronto patients showed dangerous levels of iron overload" 
(Olivieri, 2003, p. 33). This was of profound concern to Olivieri and her team because 
toxic levels of iron can cause scarring and have the potential to be life-threatening. When 
Dr. Olivieri approached her commercial sponsor Apotex (a Canadian-based 
pharmaceutical company) with her negative findings, and a request to change patient 
consent forms to include these dangers, the company disagreed that any patients would be 
at risk. Needless to say, this case raised serious questions about growing reliance on 
private sector funding for research. However, the Olivieri case is just one of many 
examples in the literature of corporate interests clashing with patients ' health (see 
Corrigan, 2005). 
Each year in the United States a quarter of a million people are experimented 
upon with one of the latest "new drugs"; however as John Braithwaite argues, the cost of 
this experimentation can only be justified if the data collection and analysis are reported 
honestly (1984, p. 51). Regrettably, pharmaceutical companies have not always met these 
standards of honest reporting. 
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Budgets, Profits and Creation of 'Disease Markets' 
In addition to manipulating the research community and controlling the 
dissemination of findings , there is evidence to suggest that the pharmaceutical industry 
also has influenced doctors ' prescribing patterns by sponsoring educational upgrades. The 
total annual marketing budget of the u.s. pharmaceutical companies, including ads, 
sponsorship of medical conferences and provision of drug samples to doctors, "topped 
$22 billion in 2003" (McDonough, 2005). According to Ted McDonough, doctors have 
now become a prime target of pharmaceutical companies' marketing simply because 
prescription drugs cannot be sold to consumers without exactly that: a prescription. 
Moreover, most of the $22 billion discussed above is spent on directly persuading doctors 
to diagnose certain conditions and treat them with a particular company's latest "new" 
drug, primarily through free drug samples distributed by the drug company 
representatives (McDonough, 2005). These representatives, also known as "detailers," are 
a very important part of a pharmaceutical company' s promotion process for their drugs. 
According to Moynihan and Cassels, drug representatives show up at doctors' offices 
bearing "food, flattery and friendship-and lots of free samples" (2005, p. 22). This pays 
off in the end for the pharmaceutical companies since doctors exposed to company 
representatives are more likely to favour drugs over non-drug interventions and more 
likely to prescribe medication when equally effective alternatives are available 
(Moynihan & Cassels, 2005). 
Furthermore, doctors are frequently paid by pharmaceutical companies to attend 
drug company "talks." Often, however, these lectures are given by medical experts who 
are sponsored by pharmaceutical companies (Moynihan & Cassels, 2005, p. 26). In 
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addition, practicing doctors are sponsored by the pharmaceutical companies to attend 
such events in locations around the world and are also offered airfare, hotel 
accommodations and special receptions and parties "on the house" (Moynihan & Cassels, 
2005). Braithwaite argues that the values of these "gifts" indeed "bear a relationship to 
how heavy a prescriber of the company's products the doctor is, or likely to be" (1982, p. 
211). In many studies done on physicians who get visits from sales representatives, 
"evidence of over-prescribing has been found" (Braithwaite 1982, p. 213). Moynihan and 
Cassel argue "contacts between detailers and doctors tend to lead to less rational 
prescribing habits" (2005, p. 24). Under these conditions, can practicing physicians trust 
the information they receive about the medication they are prescribing? As Marcia Angell 
argues it is important that "doctors' judgment about their prescription [be] based on real 
research and education, not on the marketing that passes for it." (Angell, 2004, p. 172). 
All of these "freebies" add to the cost of the drug itself. Angell notes that such gifts given 
to doctors to bribe them to prescribe more drugs are in fact illegal, yet companies get 
away with it because' gift giving' is accepted if it is said to be used for "educational" or 
"research" purposes (2004, p. 137). As potentially helpful as modern medical research 
can be, most critical social science researchers agree that it is crucially important for steps 
to be taken to properly educate doctors and consumers. Scientific research findings 
sponsored by pharmaceutical companies must be regulated to prevent the interests of 
profit-seeking corporations pursuing medicalization from overshadowing the interests of 
people's health. 
After reviewing this literature on medicalization it may not be surprising to learn 
that in 1999, the pharmaceutical industry was the most profitable industry in the United 
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States, with an 18.6 percent return on revenues (Conrad & Leiter, 2004, p. 161). 
Moreover, Angell noted that the ten American drug companies in the Fortune 500 list for 
2002 ranked higher than all other American industries in percentage of sales, assets and 
shareholders' equity. Interestingly, the combined profits for these ten drug companies 
were more than those of all of the other 490 businesses put together (Angell, 2004). 
Prescription drug spending in the United States continues to rise more rapidly than 
anywhere else, "increasing by almost 100 percent in just six years" (Moynihan & Cassels, 
2005, p. xiii). Similarly, total spending on drugs in Canada was "almost $20 billion in 
2003, up from $16.7 billion in 2001" (Health Council of Canada, 2005). Spending on 
drugs exceeds spending on physician services, and is second only to spending for hospital 
services (Health Council of Canada, 2005). In relation to drug spending for women in 
particular, "drugs that treat diseases and conditions specific to women including breast, 
uterine and ovarian cancers, menopause, fertility and infertility, reached $5 .7 billion in 
sales in 1995" (Turshen, 2007, pp. 105-106). Growth in drug expenditures is attributed to 
the introduction of new, more expensive drugs, but also to the fact that more people are 
taking more drugs today than ever before (See Critser, 2005). 
Although the industry's influence on the research community, doctors and 
patients is not new, their method for creating 'new disease markets ' is a relatively new 
phenomenon being discussed among researchers. Branding pills like Prozac and Viagra is 
important for sales, but branding medical conditions to create a market for new pills has 
become increasingly popular in the industry (Moynihan & Cassels, 2005, p. xiv). For 
instance, Moynihan and Cassels note throughout their book how the history of some 
relatively recent psychiatric categories, such as "Attention-deficit Hyperactivity 
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Disorder," "Social Anxiety Disorder" and "Irritable Bowel Syndrome" to name a few, 
differ from the stories of how other biomedical diseases such as diabetes were discovered 
(2005). The pharmaceutical industry's goal, according to Moynihan and Cassels, is "to 
create new ideas about illnesses and conditions . .. [and to] make the link between the 
condition and your medicine, in order to maximize its sales" (2005, p. xiv). One of the 
ways drug companies influence how people think about their common ailments is to turn 
life problems or difficult experiences into medical conditions. Moynihan and Cassels use 
many examples to illustrate their argument such as the medicalization of menopause, 
sexual difficulties and 'antisocial ' behaviour. While Moynihan and Cassels argue that 
disease definitions have expanded to include almost every behaviour as illness, 
broadening the domain of medicine beyond justifiable bounds, they also note how the 
causes of these conditions are narrowly portrayed "making it harder for us to see the 
bigger picture about health and disease" (Moynihan & Cassels, 2005 , p. xvii). The larger 
implications for society as discussed earlier by Illich, are that medication as the first 
solution often depoliticizes patients' views by locating the source of societal problems 
solely within the individual. 
Direct-to-Consumer Prescription Drug Advertising: Financial Aspects 
With medicalization now being driven more by commercial and market interests 
than by the medical profession (Conrad, 2005 , p. 3), the marketing, promotion and 
advertising of prescription drugs is becoming increasingly popular. More specifically, 
direct-to-consumer drug advertising or the promotion of information about specific drug 
treatments provided directly to consumers by or on behalf of drug companies is a key 
aspect of the medicalization of everyday life. While some direct-to-consumer advertising 
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has existed in the United States for over two decades, only recently has the 
pharmaceutical industry substantially increased its investment in targeting consumers 
directly (Conrad & Leiter, 2004, p. 161). According to Andrea Tone, in 1995 
"expenditures on DTCA for prescription drugs had reached $380 million; a decade later it 
exceeded $4 billion" (2009, p. 218). This expansion is due to the fact that "prior to the 
early 1980s, prescription products were not promoted directly to consumers" in the 
United States (Chandra & Miller, 2005, p. 32). Instead, industry advertising was placed in 
medical journals. During the 1980s however, several companies began to change their 
marketing strategies, and the first product-specific advertisements directed at consumers 
appeared. At first, there were a number of concerns around this "new" type of advertising 
and as a result, the United States Food and Drug Administration (FDA) "requested the 
industry to voluntarily refrain from advertising prescription drugs directly to the 
consumer" until the agency could study whether or not the regulations in place at that 
time would be sufficient to protect the public against DTCA (Chandra & Miller, 2005, p. 
33). This "voluntary moratorium" was lifted in 1985 and the industry resumed advertising 
heavily to consumers (Bell, Kravitz & Wilkes, 2000, p. 329). Although the FDA allowed 
pharmaceutical firms to market their drugs directly to consumers, regulations dictated 
that a DTC advertisement must include "a brief summary of indications, side effects, and 
contraindications" (Bell, Kravitz & Wilkes, 2000, p. 329). While it was easy for 
companies to meet these requirements for their magazine and newspaper advertisements, 
it was more difficult to fulfill the brief summary requirement in a broadcast 
advertisement. As a result, these regulations were "relaxed" in August of 1997 leading to 
a greater emergence ofDTC advertisements on television (Chandra & Miller, 2005, p. 
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33). Subsequently, the brief summary of a drug's indications, contraindications and side 
effects could be omitted if instructions were provided to consumers on how to obtain 
detailed information about the drug through a toll-free telephone number or a web-site 
address (Berger, Kark, Rosner, Packer & Bennett, 200] , p. 198). Since 1997, researchers 
have reported that spending on DTC advertising in the United States has continued to 
accelerate, reaching "$1. 9 billion in 1999, $2.54 billion in 2000, $2.77 billion in 2001, 
$2.71 billion in 2002, and $3.31 billion in 2003" (Chandra & Miller, 2005, p. 33). 
DTCA: Mapping the Context/or Advertising in the USA and Canada 
While Canada's Food and Drugs Act prohibits direct-to-consumer drug 
advertising, Canadians are still exposed to several pharmaceutical DTC advertisements 
per day (Gardner, Mintzes & Ostry, 2003, p. 425). According to Gardner, Mintzes and 
Ostry, this is largely a result of a policy statement released in 1996, which seemed to 
suggest "Health Canada was ready to relax its interpretation of the Act" (2003, p. 425). 
Health Canada explicitly stated that when interpreting and enforcing drug advertisements 
they would be more lenient as to the types of ads they considered illegal. Moreover, in 
November of2000, new policy was passed stating that help-seeking advertisements 
(which inform consumers of new but unspecified treatment options for diseases or 
conditions) and reminder advertisements (which provide the name of a product without 
stating its use) were legal, but not product claim advertisements (which include both the 
product name and specific therapeutic claims). While "Canadian companies are left with 
'informational' type advertising campaigns" (Pritchard & Vogt, 2006: 373), direct 
prescription drug advertising continues to be permitted in the United States. Although 
product claim advertisements that name the drug (such as Viagra) and make a connection 
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to the condition it treats (male sexual dysfunction) are illegal in Canada this does not 
protect Canadians from American ad exposure. According to Mary Vipond, the current 
state of Canadian mass media is "largely Canadian-owned but filled with American 
content" (2000, p. 4). More specifically, Vipond notes there is plenty of "spillover 
advertising" from the United States into Canada (2000, p. 79). This defeats the purpose of 
having different laws on DTCA in Canada since much of the Canadian magazine 
audience receives American magazines and is exposed to American advertisements. 
Two main bodies assist Health Canada to regulate pharmaceutical advertising to 
health professionals and consumers by pre-clearing advertisements and handling 
complaints: the Pharmaceutical Advertising Advisory Board (PAAB) (an independent 
review agency) and Advertising Standards Canada (ASC) (a not-for-profit self-regulatory 
body). According to David Gardner, Barbara Mintzes and Aleck Ostry, submissions to 
the P AAB and ASC are voluntary and as a result, advertisements are released to the 
general public without being viewed by government regulators or their delegated bodies 
(2003, p. 425).4 
Examples of Dangers Associated with DTCA 
Yet problems with DTCA are numerous. For example, according to Gardner, 
Mintzes and Ostry, "heavily advertised drugs tend to be newer and, thus, there is less 
information available regarding their relative benefits and risks" (2003, p. 426). As a 
result, DTCA promotes early uptake of many drugs, and can magnify the dangers of 
prescription drug use in cases where harm has not yet been accurately tested. According 
4 The public assumes that the government would protect their health by promoting the distribution of 
honest, accurate information about prescription drugs. See Berger, Kark, Rosner, Packer & Bennett, 200 I: 
198. 
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to Conrad and Leiter, the majority of DTC advertisements focus on a limited number of 
drugs. For example, in 2000 "20 drugs accounted for 60 percent of direct-to-consumer 
advertising" (Conrad & Leiter, 2004, p. 161). 
One major class of drugs, proven to be detrimental to patients' health after already 
being put on the market, can illustrate these points. The first to be banned were some of 
the replacement hormones for menopause. Although menopause was once a natural part 
of aging for women, a time when fertility comes to an end, it has recently been marketed 
as a "depressing" time of hormone loss, which, women are told, brings an increased risk 
of deadly and frightening disease. For instance, losing estrogens is said to bring about 
"Alzheimer's disease, heart attacks, colon cancer, cataracts, teeth loss, night sweats, 
vaginal dryness, bone fractures and more" (Moynihan & Cassels, 2005, p. 43). All of this 
negative talk is coupled with symptoms, which usually are referred to as becoming 
troublesome for women and their families (such as mood swings and hot flashes). 
Although there had been no studies yet completed on long-tenn effects, "by the late 
1980s and into the 1990s, millions of women worldwide" were taking combination 
hormone replacement therapy (HRT) (Moynihan & Cassels, 2005, p. 50). It was not until 
a few years after HRT was approved that it was found to be doing more harm than good. 
Rather than preventing heart disease (as it had been claimed they could do), combined 
hormone replacement therapy was causing it. Most social scientists agree that accepting 
this stage of life as a natural part of aging far outweighs the benefits of seeking hormone 
replacement therapy (Moynihan & Cassels, 2005; Coupland & Williams, 2002). 
Coupland and Williams argue that the medical discourse surrounding menopause gave 
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the public imprecise access to the 'facts' about this condition (Coupland & Williams, 
2002, p. 426). 
The medicalization of menopause is just one example where inessential drugs 
caused reactions leading to ill health and even death for women. While "thousands of 
patients die each year from taking medication for minor medical problems" (Strand, 
2003, p. 18), women bear the greatest burden of harm when it comes to medicalization. 
The medicalization of femininity and women's experiences is widespread. In addition to 
safety issues, feminists argue that direct-to-consumer drug advertisements "playa major 
role in reinforcing stereotypes and encouraging the administration of drugs to women" 
(Penfold & Walker, 1983, p. 198). Moreover, Tone reports on the history of tranquilizers 
stating that "tranquilizer ads consistently championed psychotropics as an antidote to 
'transgressive' female behavior: being single in a world where women were expected to 
get married, getting cranky or tired of juggling the dual demands of care giving and 
breadwinning" (2009, p. 156). 
The published works on direct-to-consumer drug advertising (DTCA) discussed 
in this chapter are replete with information on the consequences of patient overexposure 
to DTCA (see Berger, Kark, Rosner, Packer & Bennett, 2001; Mintzes, 2002). The 
literature also covers content analyses of OTCA (see for example Bell, Kravitz & Wilkes, 
2000), the effects of prescription drug advertising on pharmaceutical drug prices and 
physician prescribing patterns (Mintzes, Barer, Kravitz, Bassett, Lexchin, Kazanjian, et 
aI., 2003), the accuracy of claims made in pharmaceutical drug advertisements 
(Villanueva, Peiro, Librero & Pereiro, 2003; Cooper & Schriger, 2005), and the quality 
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and quantity of graphs in pharmaceutical advertisements (Cooper, Schriger, Wallace, 
Mikulich, & Wilkes, 2003). 
What this study will be adding to the literature 
This review of the literature has shown the ever increasing concern amongst 
scholars about medicalization, medical power and influence, and more recently DTC 
advertisements and their effect on the expansive potential of medical categories. The 
researchers have shown how DTCA is a key tool in the medicalization of everyday life, 
and how many ads target women and have specific effects on the medicalization of 
women' s lives. There has not been much research done on discourses in pharmaceutical 
drug advertisements (although Jonathan Metzl's Prozac on the Couch looks at 
advertisements for psychotropic medications in professional journals). Furthermore, there 
has been no focus on medicalization and women in relation to pharmaceutical drug 
advertisements in O. The Oprah Magazine specifically, which, as a large-circulation and 
very influential women's magazine, has a significant impact on a wide female audience. 
This is the goal of this study. Approaching my analysis from this perspective holds the 
promise of increasing awareness about the consequences of accepting pharmaceutical 
discourses around health and illness. 
The next chapter discusses critical discourse analysis as a useful methodology for 
understanding DTCA in the context of 0 Magazine. 
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CHAPTER THREE: METHODS - CRITICAL DISCOURSE ANALYSIS 
Introduction 
The methodology used in this study is a qualitative critical discourse analysis of 
pharmaceutical drug advertisements in 0 , The Oprah Magazine. Since the language and 
visual communication techniques used in pharmaceutical advertisements are carefully 
crafted to meet particular ends, studying these ads is meant to lead to a clearer 
understanding of what discourses are conveyed to readers in relation to health, illness and 
medication. Critical discourse analysis is a method that can facilitate understanding about 
direct-to-consumer drug advertisements and the meanings they convey about health, 
illness, and medicine. 
Critical discourse analysis is also useful because it is an unobtrusive 
methodology, and therefore does not "intrude as a foreign element" into the social 
settings this thesis seeks to describe (Lee, 2000, p. 2) . Critical discourse analysis takes a 
particular interest in the relation between language and power, and as such seems to be a 
valuable research tool for exploring medical discourse and its connection with power and 
control. In this way, critical discourse analysis provides a useful approach to better 
understand the potential problems caused by pharmaceutical drug advertising by 
illuminating the ways in which discourses reiterate particular ideas around health, illness 
and treatment. 
What is Discourse? 
Before understanding what critical discourse analysis is, it is important to 
understand first, what is meant by the term discourse. Discourse is described differently 
in different disciplines such as linguistics, psychology and sociology. "Multiple 
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perspectives on discourse mean that there are multiple definitions of discourse and of 
what counts as discourse (eg, spoken language, written language, language use above the 
level of the sentence, etc.)" (Wood & Kroger, 2000, p. 3). Discourse, according to Gillian 
Rose, "refers to groups of statements which structure the way a thing is thought, and the 
way we act on the basis of that thinking" (2005 , p. 136). According to Sara Mills, 
"discourses structure both our sense of reality and our notion of our own identity" (2004, 
p. 13). Thus, the term discourse "refers to much more than simply printed text" (Mills, 
2004, p. 225). Discourse is therefore useful in that it can allow us to "analyse similarities 
across a range of texts as the products of a particular set of power/knowledge relations" 
(Mills, 2004, p. 21). Although there is not a single, clear definition of discourse, and 
therefore not one but multiple ways of using critical discourse analysis as a research 
method, all definitions point to the fact that critical discourse analysis provides a unique 
opportunity to examine texts in a number of meaningful ways. 
Why Critical Discourse Analysis rather than Discourse Analysis? 
Discourse analysis is loosely defined as "the close study of language in use" 
(Taylor in Wetherell , Taylor & Yates, 2001 , p. 5). Discourse can also refer "to the full 
range of practices, structures, and media that saturate our world and ourselves with 
meaning," and therefore, contributes to how knowledge is constructed and produced 
through social relations (Carroll, 2004, p. 225). The notion of being critical , according to 
Ruth Wodak, is to be understood as "having distance to the data, embedding the data in 
the social, taking a political stance explicitly, and a focus on self-reflection as scholars 
doing research" (in Wodak and Meyer, 200], p. 9). Thus, employing a critical discourse 
analysis is essential to make connections between texts and our social world. According 
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to William Carroll, critical discourse analysis (as opposed to simply discourse analysis) 
"provides ways of challenging systems of knowledge and power by interrogating and 
contextualizing dominant discourses" (emphasis in original, 2004, p. 225). In general 
"CDA asks different research questions" than other qualitative methods (Meyer, in 
Wodak & Meyer, 2001, p. 15). Teun Van Dijk argues "CDA is a - critical - perspective 
on doing scholarship: it is, so to speak, discourse analysis 'with an attitude'" (in Wodak 
& Meyer, 2001, p. 96). The purpose of critical discourse analysis, then, is to think of 
discourse as having particular effects on particular people (Mills, 2004, p. 16). This study 
is not focused on the linguistic notion of discourse (which would look at specific 
constituent units and sentence structure in the ads), but rather on the broader meanings 
that both the visual and textual elements of the ads convey, in order to discover how they 
structure meaning around pharmaceutical drugs and illness in 0 Magazine specifically. 
Why Critical Discourse Analysis is usefulfor this study 
Critical discourse analysis or CDA is meant to provide an increased awareness of 
the multiple meanings and assumptions that can be encoded in advertising, thus creating 
space to explore beliefs and to include critical analysis within the debate. For instance, 
through the mass media, dominant groups attempt to exert control over access to public 
discourse. Moreover, "language is entwined in social power in a number of ways: 
language indexes power, expresses power, [and] is involved where there is contention 
over and a challenge to power" (Wodak, in Wodak and Meyer, 2001, p. 11). So although 
discourses in the media often use language to reinforce their own position of dominance, 
critically analysing these discourses can facilitate change. Michael Meyer states that 
critical discourse analysis "follows a different and a critical approach to problems, since 
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it endeavors to make explicit power relationships which are frequently hidden, and 
thereby to derive results which are of practical relevance" (in Wodak and Meyer, 2001, p. 
15). By taking an interest in the ways in which discourses are used in various expressions 
and manipulations of power, CDA can not only discover when and how power is 
exercised, but also create opportunities to challenge it. 
There are multiple ways of doing a critical discourse analysis since discourse 
analysis can function as both a theory (a way of thinking about discourse) and a 
methodology (using discourse as data). Critical discourse analysis provides an 
understanding of discourse that is both sociological (to recognize the structuring of text) 
and post-modern (to identify the interactional dimensions of discourse) (Carroll, 2004, p. 
264-265). In relation to my research, further understanding the complexities of language 
used in pharmaceutical texts can create critical awareness of the ideological processes 
within the discourse. Thus, CDA will enable an understanding of the ways in which 
knowledge is organized and communicated in specific places. 
Concerns about CDA 
Although this methodology seems appropriate for my research, there are 
inevitably authors that discuss its inherent weaknesses and implications. Critical 
discourse analysis can be criticized for being a matter of interpretation. For instance, 
Widdowson argues that critical discourse analysts confirm their own values, that CDA is 
a merely a subjective process (Widdowson, 2004). However, any account of a social 
phenomena or situation inevitably reflects the researcher's own partial understandings 
and special interest. This research does not aim to provide one knowledge or Truth, as 
this would deny the diversity of viewpoints and experiences of others who are involved in 
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the subject ofthe study. So although some researchers assume that the knowledge 
obtained in this study will be partial and relative (related to my world view and value 
systems), it can be said that all arguments are subject to their own deconstructive readings 
and counter-interpretations. Moreover, since complete neutrality is impossible, Stephanie 
Taylor suggests "the researchers' influence must be taken into account and even utilized" 
to some extent (in Wetherell , Taylor & Yates, 2001, p. 17). As long as I attempt to 
understand the influence of my own presence and actions - including the relevance of my 
own identity to the research - then I can be aware of the potential ethical complexities I 
bring to this study. 
David Gauntlett states "we cannot assume that these messages have a direct 
impact on people, of course; and it is not necessarily the case that the mass media are 
adding these messages into society - perhaps the media are only circulating ideas which 
already seem like common sense to many people" (2002, p. 123). While this study will 
not be able to assess if the discourses in pharmaceutical drug advertisements directly 
affect people's decision-making and thus contribute to medicalization, we know from 
Chapter Two that medicalization is on the rise as more people actively seek out 
medication. A critical discourse analysis of these magazine drug advertisements can 
facilitate different knowledges regarding the pharmaceutical industry, as well as their 
meanings and significance, "but also [it will] root out a particular kind of delusion" by 
creating awareness through "demystifying" pharmaceutical discourses (Wodak, in Wodak 
and Meyer, 2001, p. 10). 
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Research Source and Sample 
Direct-to-consumer (DTC) advertising of prescription drugs is widely used 
throughout North American in varied forms such as TV, radio, magazines, and 
newspapers. Magazines in particular have become a very specialized medium for the 
dissemination of information. In fact, there are about 500 consumer magazines in Canada 
(Berkowitz, Crane, Kerin, Hartley & Rudelius, 2003 , p. 503). I have chosen 
pharmaceutical drug advertisements appearing in four issues of 0 , The Oprah Magazine 
from 2006 as the material for critical analysis in this research study. I chose this specific 
magazine for several reasons. First, Oprah Winfrey is one of the most successful and 
influential women in the world (Illouz, 2003 ; Wilson, 2003). Although Oprah' s magazine 
is fairly new (launched in April of2000), it became immediately prosperous and was 
called "the most successful magazine start up in history" (Illouz, 2003, p. 3). The obvious 
cultural visibility and economic size of the Oprah phenomenon provides a good reason to 
undertake a study centering on ads in her magazine. Secondly, 0 Magazine is a monthly 
magazine with an average monthly circulation of2,394,303. Thirdly, this US magazine 
was chosen over a Canadian magazine because, as mentioned in Chapter Two, Canadian 
magazines are forbidden to have product claim direct-to-consumer drug advertisements. 
As a result, the ads found in American magazines are geared more towards "selling 
sickness" (as Moynihan and Cassels would label it) and carry more content for analysis. 
Also, American magazines tend to dominate Canadian magazine stands due to border 
seepage, and are therefore just as popular here as in the US (Vipond, 2000). 0 
Magazine's total paid and verified circulation (including paid subscriptions and single 
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copy sales) in Canada specifically for the January 2008 issue was 153,711 (omediakit, 
advertising, 2008). 
Using drug advertisements as a main source of data rather than other 
advertisements found in 0 Magazine is important because prescription medications 
directly affect the health of people and as a result, "have greater social relevance than the 
products of almost any other industry" (Gereffi , 1983, p. 167). Of the drug 
advertisements in 0 Magazine , 21 are utilized for analysis, taken from four issues of the 
magazine in 2006: January, April , July and October. These ads from 2006 provide the 
most current data possible for this thesis study. These 21 advertisements will prove to be 
examples of the larger points made about the industry (as discussed in Chapter Two). 
Advertisements from different pharmaceutical companies were sought (for 
example Novartis, Pfizer, etc) to gain a representative sample of the pharmaceutical 
industry in general, rather than one company specifically. The advertisements collected 
for analysis vary in content. Some advertisements promote prescription drugs for minor 
ailments such as constipation/abdominal discomfort and allergies. There are also ads for 
mood disorders such as depression and bipolar disorder as well as for potentially life-
threatening conditions like breast cancer and blood clots. Since I am reviewing ads in a 
women's magazine, the goal of this thesis is to analyze advertisements directed mainly at 
women. 
This research is focused on analyzing prescription as opposed to over-the-counter 
drug advertisements because "over-the-counter drugs are generally safe and are for 
conditions that do not require a physician's diagnosis" (Mintzes, 2006, p. 5). 
Prescription-only products on the other hand, are "generally more toxic and used to treat 
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conditions that are not easily self-diagnosed and self-managed" (Gardner, Mintzes & 
Ostry, 2003 , p. 426). Moreover, repeats of advertisements that are exactly the same in 
size, image and content are not included. Last, an advertisement for bipolar disorder that 
was not directly associated with any prescription drug was included in this study because 
it was associated with Seroquil on the website provided in the ad. While treatment for 
more "legitimate" diseases such as cancer and blood clots have been known to provide 
dramatic benefits and are often not of concern to social researchers, I have included these 
ads along with the "new" drugs which provide marginal health benefits, are increasingly 
unaffordable and carry more risks of adverse drug reactions (Health Council of Canada, 
2005). My goal is to explore the common discursive themes among different types of 
pharmaceutical drug ads. 
Data Processing and Analysis 
My first step in this analysis was to thoroughly review each advertisement to 
familiarize myself with the data and contemplate the essence of what these ads were 
communicating. Next, I coded or categorized the 21 prescription drug advertisements. 
Coding, according to John Creswell, "is the process of segmenting and labeling text to 
form descriptions and broad themes in the data" (2002, p. 266). Since discourses are 
articulated through visual and verbal images and texts and also through the practices that 
those languages permit, I considered all of these elements in analyzing the discourses. 
Rose also suggests using the coding process as a systematic method which will allow key 
themes to be identified (through key words or recurring images) (Rose, 2005 , p. 150). 
This involved reviewing all of the ads again and summarizing the meaning of text 
segments as well as visual images with one or two code words. During this process, I 
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asked questions ofthe data such as "What does this really mean?" "What is being done 
here?" and "What theme do you belong to?" This idea of asking questions while coding 
came from Sandra Kirby, Lorraine Greaves and Colleen Reid's book Experience, 
Research, Social Change: Methods Beyond the Mainstream (2006, p. 232). The more 
questions I answered, the more understanding I had about what was going on in the 
advertisements. 
Once coding was complete, I worked at developing broader themes or categories 
that reflected issues confirmed or missing in previous research on medicalization, the 
pharmaceutical industry and direct-to-consumer advertising. For this particular part of the 
analysis, I wrote each code onto separate cue cards and clustered together similar codes. 
After much labeling and sorting, I managed to condense the original 150-200 codes into 
three discursive themes: traditional gender role discourse, normative discourse and 
responsibilizationlautonomous discourse. I report on these findings in detail in the 
following chapter (Chapter Four), where I also look at the range of practices in 0 
Magazine which support the discourses found in the ads. 
Conclusion 
As sources of information about health, illness, and treatment of symptoms, 
prescription drug advertisements need close critical study due to the ideological influence 
they potentially wield. Indeed, pharmaceutical drug advertisements seem a particularly 
clear example of texts as sites of influence. Thus, CDA can explore how these texts 
function both in terms of marketing and in terms of social messages. It would be 
simplistic to say that the pharmaceutical companies who make these prescription drug ads 
and the people who edit 0 Magazine are malicious, and that their readers are victims. 
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Gauntlett argues that "the debate needs to be more sophisticated, productive and 
sympathetic" than that (2002, p. 207). Thus, using this methodology will result in more 
awareness of the qualities and shortcomings of pharmaceutical drug advertising, and 
contribute to a more informed debate on the industry's intentions in the minds of readers. 
The next chapter discusses how the pharmaceutical industry actively constructs 
and employs discourses through direct-to-consumer advertisements in 0 , The Oprah 
Magazine. 
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CHAPTER FOUR: THE FINDINGS, WHAT THE ADS ARE SAYING 
To put the findings of this study into context, this chapter begins with a 
background on advertising strategies used by pharmaceutical companies in 0 Magazine. I 
then analyze the data of the study in two parts: a critical discourse analysis of the ad 
sample, and an analysis of 0 Magazine's practices which support these discourses. 
Advertising Strategies in the Context of 0 Magazine 
Magazines are an excellent medium for advertisers because they last longer than 
other media: they continually get passed around and re-read. As a result, advertisements 
are seen for a longer period and more often by more people. Furthermore, "print is more 
productive, dollar for dollar, than television . .. because the more heavily employed any 
medium becomes, the more it is laden with the clutter of advertising messages from 
everybody in the market" (Jones, 2002, p.103). Since television has more and more 
advertisements, advertisers will encounter progressively lower productivity from their 
advertising dollars. According to John Philip Jones, "magazines and radio offer ways of 
stretching cost-efficient reach" (Jones, 2002, p. 103). Although Jones also suggests 
multiple media as an increasingly valuable process, magazines give media directors a lot 
of options - they can place their ads on fractional pages, multipage inserts, single pages 
etc. Moreover, magazines are integrated with the internet. "Most major magazines also 
have Websites, which opens all kinds of promotional and cross-promotional opportunities 
for print and online advertisers" (Altstiel & Grow, 2006, p. 196). 
Once advertisers establish magazines as their medium, they use a number of 
techniques to make the advertisement successful. In general, advertisements try to 
incorporate a combination of the following characteristics, depending on the product and 
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the consumer: the ad will provide information, highlight the benefits of a product, 
intrigue the reader, sell an image, command the reader to do something, impress the 
reader and stand out (by differentiating their brand from the competitor) (Altstiel & 
Grow, 2006). I will now explore the rationale for why advertisers might choose 0 
Magazine, followed by a discussion of the main advertising techniques found in 
pharmaceutical advertisements featured in the four issues of 0 Magazine used for this 
study. 
Marketing plans, according to William Luther, author of The Marketing Plan, 
begin with knowing who your consumers are and what they want and need (2001, p. 53). 
In its online media kit 0 Magazine is said to have an audience of 89% female readers, 
mostly between the ages of 18-54. Also, more 0 Magazine readers (compared to other 
magazines such as Vogue, Glamour, Martha Stewart Living and Redbook) are reported as 
being from affluent households, from $75K up to $200K. 0 Magazine also claims to 
deliver to more moms and reach more readers with college degrees than other magazines. 
Advertising is dependent on whether the customer will see the advertisement. 
Luckily for advertisers, 0 Magazine is one of the best vehicles in any medium for 
reaching women. For instance, statistics from 0 Magazine's media kit show that the 
magazine reaches 3.9 million women per month between the ages 18-34, out-performing 
other magazines (such as In Touch, Self, Elle), websites (such as MTV.com, E! Online, 
Cosmopolitan.com) and even TV shows (such as American idol, Grey's Anatomy, 
Desperate Housewives, So You Think you Can Dance and America's Next Top Model). 
But advertising in 0 Magazine does not assure advertisers that their particular ad will be 
seen. The advertising writers must also think of a message "compelling enough - or 
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friendly and intriguing and involving enough - to cause some consumers to pause before 
they switch off their mental engagement and then to stimulate some of the people who 
pause to go on further" (Jones, 2002, p. 33). One of the ways to grab readers' attention is 
to show the consumer how they can benefit from the product (Jones, 2002, p. 35). Most 
of the ads analyzed for this study open with a direct benefit to the reader. For example, an 
ad for Lunesta (a sleep aid medication) opens with the message "Discover Lunesta, a 
sleep aid that can change your nights" (Figure A.2). Similarly, an advertisement for 
Imitrex states "why let a migraine ruin your life? Get back to your life with Imitrex." 
However, some ads attempt to sell their product's benefits through more indirect means, 
by promoting values, images and concepts of love, success, romance and normalcy. This 
will be discussed in more detail later in this chapter. 
According to Tom Altstiel and Jean Grow, authors of Advertising Strategy, there 
are many "nonfact claims" routinely used in advertising. Puffery, for example is "the use 
of superlatives to tout the greatness of your brand - making it so obvious that consumers 
are bound to know the claims are exaggerated" (2006, p. 13). Many pharmaceutical 
advertisers in this study use puffery. For example, an advertisement for Zyrtec, a 
medication used to treat allergy symptoms, states that it is the "#1 prescribed allergy 
medicine in the country." Similarly, an advertisement for Zoloft, a prescription drug used 
to treat depression, states that it is "#1 for millions of reasons." The use of puffery is used 
to impress the reader but advertisers must also work hard to differentiate their particular 
brand from their competitors. One way to stand out amongst the competition is for 
advertisers to talk about their product as being the only solution. According to Jones, 
"unless a brand has functional features superior to the competition in at least some 
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respects, it will not be bought repeatedly" (2002, p. 35). An advertisement for Botox 
Cosmetic claims Botox is "The ONE. The ONLY" while an ad for Zelnorm (for 
abdominal discomfort) states "Only prescription Zelnorm helps coordinate the nerves, 
muscles and fluid in the OJ tract, so it can start functioning more normally - and you can 
start feeling better." Secondly, competitors separate their brand from others by stating up 
front the negative effects it is not associated with. For instance, Wellbutrin XL is better 
than other brands because it works for depression "with a low risk of weight gain and 
sexual side effects.,,5 Similarly, Imitrex for migraines will give you "the relief you need, 
without drowsiness." 
Advertising is also about connecting with the reader, and finding a way to 
establish a personal relationship with customers. Luther argues that it is important for 
companies to invest interest in their customer's welfare because "people buy from 
individuals they like" (2001, p. 106). The pharmaceutical companies behind the 
advertisements used in this study certainly work hard to build such relationships with 
their readers. For instance, many ads offer free samples, financial assistance/incentives, 
alternative health coverage options, as well as phone numbers to call and websites to visit 
for further assistance. An advertisement for BOTOX states: "to find a doctor in your area 
visit www.BotoxCosmetic.com ... At the bottom of an ad for Zyrtec can be read : 
"Uninsured? Need help paying for medicine? Pfizer has programs that can help, no 
matter your age or income. You may even qualify for free Pfizer medicines. Call 1-800-
706-2400. Or visit www.pfizerhelfulanswers.com ... Similarly an ad for Arimidex, a 
cancer prevention medication, states: "To learn more about Arimidex, or if you are 
5 It is well known that other antidepressants can cause serious sexual difficulties. See Moynihan & Cassels, 
2005, p.33. 
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without prescription coverage and cannot afford medication, AstraZeneca may be able to 
help. Call or visit us online." An advertisement for Zelnorm offers free tips for talking to 
your doctor and a card to fill out and bring with you to your appointment (see Figure 
A.3). 
To further develop a relationship with the consumer, advertisers must establish 
trust. Some advertisers do this by stating facts about their product. An advertisement for 
Zyrtec, for example, states: "For the past 10 years, millions of people have turned to 
Zyrtec to treat their allergy symptoms." Other advertisers use statistics from clinical trials 
to gain consumers' trust. Femara, a drug used to reduce the risk of breast cancer 
reoccurrence, states: "Femara was generally well tolerated in two controlled clinical 
trials." These techniques provide the reader with an image of pharmaceutical companies 
as helpful , one that they can connect with. Helpful messages tell the reader that 
pharmaceutical companies understand what they are experiencing and are trustworthy. 
Other techniques found in the ads are the use of rhymes and riddles, cartoons 
versus real people, the use of the present tense, the use of the word patient (inferring the 
reader is already a patient), and ' before and after' images. It should also be noted that 
advertisers usually feature beautiful people in their ads. 
Advertisers must also include some necessary components in each advertisement 
for pharmaceutical drugs. These include a list of common side effects, indications and 
contraindications, precautions, dosage and administration, drug abuse and dependence, 
and reactions. Most of this additional information is found separate from the actual 
advertisement, always on the back page (rather than on a 2-page spread) (see Appendix 1 
for examples). This type of information must be included because oflabeling 
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requirements with regard to drug products (See Mintzes, 2006 for the difference in 
regulatory requirements and restrictions between Canada and the USA). 
Data Analysis Part One - Critical Discourse Analysis of the Ad Sample 
The [pharmaceutical] industry has promoted the universality of symptoms of 
emotional distress, aided in the inclusion of problems of living within the scope of 
medicine, and reinforced popular convictions about the right to avoid suffering, 
the pursuit of eternal youth and constant happiness (Susan Penfold and Gillian 
Walker, 1983, p. 193). 
This section will look at the study findings using critical discourse analysis as 
applied to the selected ads. In analyzing the ads, three areas of discourse emerged. First, 
traditional gender roles reflected in the advertisements and how they intersect with 
medicalization will be discussed. I will then discuss the normative discourses reiterated in 
the pharmaceutical advertisements around "proper" behaviour and appearance. Lastly, I 
will discuss how the pharmaceutical companies behind the advertisements rein scribe 
autonomy and responsibilization discourses in order to sell their product. Next, each 
theme will be laid out separately. 
Traditional Gender Role Discourses 
Of the 21 advertisements gathered for this particular analysis, 16 featured women, 
another made reference to a woman in the text, two more featured pictures of children, 
one was a silhouette of four men and one ad featured a man as the patient (see Appendix 
1). The discourses emerging from pharmaceutical ads regarding women and gender role 
stereotypes, discourses that are at the heart of feminism, remain present in advertisements 
today. Gauntlett argues that historically advertisements in women's magazines 
represented women as "simpering housewives whose dream was to impress their 
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authoritative, working husbands" (Gauntlett, 2002). Also, the traditional components of 
sexual identity for a "healthy personality" are said to consist of "a preference for 
members of the opposite sex; a clear-cut sex-role identity as either masculine or feminine, 
depending on one's sex; [and] a gender identity, a secure sense of femaleness or 
maleness" (Penfold & Walker, 1983, p. 92). Ads can reiterate these discourses by 
featuring women who are with men (both of which have clear gender identities). They 
then present medication as being key to their happiness or their ability to function in this 
role. These discourses are present in many of the advertisements analyzed for this study. 
Three examples illustrate how these discourses are used by pharmaceutical 
companies to promote their medication. The first, an advertisement for IMITREX (Figure 
AA), asks "Why let a migraine disrupt your life?" The sufferer is a middle-aged woman 
with anguished eyes, clenched teeth, and her left hand pressed firmly against her left 
temple. She is pictured sitting at a table in a nice restaurant with her husband (her 
wedding band is clearly visible on her left hand). There is a "migraine monster" featured 
ripping through the page, placed between the woman and her husband, clearly disrupting 
their romantic dinner. The message here is clear: the woman needs to medicate herself in 
order to be able to function fully and fulfill her role as a wife. In this example, the woman 
has not yet sought treatment for her condition. 
The second and third example, however, illustrate the contentment a couple can 
achieve through medication post-diagnosis. A Zyrtec advertisement (Figure A.5) features 
a heterosexual couple in a boat fishing together. The words below the picture read 
"Thanks to her Zyrtec, Kelly can spend Saturday with her outdoorsman." The focus here 
is again on the woman and her ability to be with her male partner. Although there is no 
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wedding ring visible, the caption alerts the reader that the two are in a romantic 
relationship. The third example is for a depression medication (Figure A.6). In this ad an 
attractive heterosexual couple sits opposite each other in a row boat on a sunny day. The 
woman ' s left hand, with a wedding ring visible, is resting on the side of the boat as she 
enjoys the scenery. The man has both hands placed on the oars; he is the one in charge of 
rowing the boat. The caption at the top of the page reads "WELLBUTRIN XL works for 
my depression with a low risk of weight gain and sexual side effects" while the caption at 
the bottom of the ad states "Experience Life." The ad is telling us that depression can take 
away from one's ability to enjoy daily life experiences, but that WELLBUTRIN XL is 
the answer not only for depression, but for the symptoms other depression drugs currently 
cause: weight gain and sexual side effects. The ad implies that with WELLBUTRIN, you 
can still remain thin and have the desire to please your partner, which will allow you to 
"Experience Life." This ad from the April 2006 issue of 0 Magazine is demonstrative of 
the ways in which gender and identity are discursively linked to a brand-name 
prescription. The discourses in these three advertisements form an understanding around 
women's role while promoting medication to improve women's capacity to take on that 
role. 
All of the three ads mentioned have images and captions that construct discourses 
around women's ability to pull themselves together in order to participate in activities 
with their male counterparts, while looking appealing at the same time. Consequently, 
these discourses strongly suggest that "inability to function in a traditional female role, 
inability to cope with being a woman and with woman's tasks, need to be treated with 
medication" (Penfold & Walker, 1983, p. 199). These portrayals of "proper" femininity 
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and the message that the featured drugs would be greatly effective are the immediate 
discourses used to encourage a certain understanding in readers about themselves and 
their need for medication. 
Gendered expectations for feminine fulfillment are also represented through size 
and rank of the people presented in the advertisements. In Gender Advertisements, Erving 
Goffman notes that the "social weight [of] power, authority [and] rank" can be expressed 
in advertisements through the relative size of the people in them (1979, p. 28). Of the 
three ads which feature couples, there is only one where the woman is pictured larger 
than the man (see Figure AA). Here the man does not appear subordinated because of 
class status or rank but by the fact that his wife remains untreated. 10hnathan Metzl 
argues that when a woman appears larger than a man in an advertisement, it "presents her 
as a threat" (Metzl , 2003, p. 138). Again the woman is shown to be in need of medication 
to fulfill her proper gender role. In the other two advertisements featuring couples, the 
man appears larger (see Figures A.5 and A.6). The male is not only larger but he also 
appears to be in charge. In the Wellbutrin ad (Figure A.5) for instance, the male is 
pictured rowing the boat while in the Zyrtec ad (Figure A.6) the male is pictured wearing 
a vest with multiple pockets holding fishing lures, with a knapsack in front of him. These 
subtle differences in size and specific clues as to role positioning show the reader that the 
female is subordinate to her husband or partner. In these cases, traditional gender roles 
are represented through size and rank while at the same time being linked with a brand-
named prescription. 
The importance of fulfilling particular gender roles is also reinforced in more 
subtle ways, such as the presence of wedding rings in advertisements. Metzl argues that 
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middle-aged women wearing wedding rings in pharmaceutical drug ads imply 
"normativity, stability, and adherence to social mores" (2003, p. 135). Also, Gauntlett 
argues that magazine advertisements in general "are accused of suggesting that a man is 
the route to happiness" and that relationships with them should be an important goal for 
women (2002, p. 190). Wedding rings were clearly visible in four out of the 16 
advertisements featuring women (See Figures AA, A.6, A.7 and A.3). The 
advertisements for Imitrex and Wellbutrin discussed above are illustrative ofMetzl's 
argument as are two other advertisements, one for Relpax, a migraine medication, and 
another for Zelnorm, a pill that relieves abdominal discomfort, bloating and constipation. 
In the Relpax advertisement, a middle-aged African American woman is shown with both 
hands raised to her temples. Her eyebrows are furrowed and she appears to be in pain. 
There is a pair of cymbals drawn around her head mimicking the "banging" the woman is 
experiencing from the migraine headache. The ad reads: "A tough migraine needs a tough 
migraine medicine." The ring represents tradition because marriage is a custom in North 
America and a life goal to which most women are supposed to aspire. In the Relpax ad, 
relating traditional discourses about marriage to migraine medication is significant 
because it makes the advertisement appealing to readers who have these desires in life. 
The more different groups of people can relate to an advertisement, the more likely it is 
that the company will sell its product (Beasley & Danesi, 2002, p. 102). Second, the ring 
reflects stability by locating the woman in the advertisement within the larger narrative 
structure of a heterosexual relationship. The migraine she is experiencing is threatening 
that unit of which she is a part. The smaller print below the advertisement reads: "Relpax 
works fast. For some people it starts to work in 30 minutes. Most get back to their day in 
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2 hours." Conversely and ironically, the relationship the woman is in could also be the 
cause of her migraine. This interpretation reinforces Metzl' s assertion that "marriage is 
not an institution that empowers women to become domestic superwomen; it is an 
arrangement that drives middle-aged [women] to visit [their doctors]" (2003 , p. 141). 
Making an advertisement's interpretation multifaceted allows the ad to appeal to a wide 
range of readers at the same time. Such discourses are intentionally included in the 
advertisements.6 With one simple wedding ring, this advertisement has signaled 
significant gender stereotypes and linked each discourse to a brand-named chemical cure, 
which in this case is Relpax. The Zelnorm advertisement (Figure A.3) also uses the 
subtleness of a wedding ring to reflect traditional gender discourses around marriage and 
connect it to medication. In this ad the woman is suffering from chronic constipation and 
her stomach is slightly toppling over her pants. The wedding ring here again symbolizes 
and reiterates the traditional aspect of marriage and stability. Like the Relpax 
advertisement, this ad has the potential to relate to both married women and those who 
hope to get married in the future . The following words are written on the woman's 
stomach: "Abdominal discomfort, Bloating, Constipation." No matter how uncomfortable 
this condition makes the woman in the ad, there is still a discourse around the comfort of 
the fact that she is married. As well as reflecting stability through the presence of a 
wedding ring, this ad reinscribes traditional gendered discourses around marriage and 
sex. Sex is considered to be a customary part of a couple ' s marriage, so the reader can 
assume that the woman is indeed sexually active with her partner. However, body image 
can be affected by abdominal discomfort and body image can affect one's desire to have 
6 Noth ing in advertising is random or accidental ; all details are considered for their impact on the potential 
consumer. See Steinem, 1994, p. 155-161 . 
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sex - but Zelnorm can help relieve all the discomfort the woman in the ad is 
experiencing. Here we can see the promotion of a drug through discourses around 
marriage and gender roles brought about by the presence of a wedding ring. 
Discourses surrounding a woman's traditional role as wife, mother and caretaker 
within the home are also reflected in advertisements through the promotion of children' s 
medications. Since 0 Magazine has a predominantly white, middle-class, female 
readership, we can conclude with a fair amount of confidence that the advertisements for 
children's medications are directed at women who fit these criteria. An advertisement for 
Pulmicort Respules, a children ' s asthma medication, reflects this point (see Figure A.8). 
The first caption reads: "Does your child's asthma medicine fit your child?" In this 
statement the parent or guardian of the child (most likely the mother) is being addressed 
rather than the child. Moreover, the question emerges from current societal discourses 
around anxiety and fear about proper parenting. An advertisement for a new ADHD 
patch is also directed at mothers (Figure A.9). One statement in the ad reads: "When you 
apply the Daytrana patch, you can help your child get ready for school , homework, and 
his entire day.,,7 Here women's traditional roles as caretakers of the home and children 
are reiterated. The statements used in both ads reflect traditional discourses around 
women and gender roles. From the point of view of the pharmaceutical companies, these 
discourses can help them to relate to woman readers and increase women 's awareness of 
their product. 
The same discourse can also be seen in an ad directed at men. The ad for 
Roserem, a sleep aid medication, features a man who is struggling to control his sleeping 
7 Here the patient is a young male and more boys are diagnosed with ADHD than girls. See DeGrandpre, 
1999. 
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pattern on his own, but in the ad he appears to be unsuccessful. Here Roserem provides 
that control. However, since 0 Magazine readership is predominately composed of 
women, this ad is directed at Dr. Mom who through it is assumed to be responsible for 
the health of her husband and children. 
Normative Discourses 
Normality is not a thing that can be plucked out of its surroundings and 
identified. It depends on an interaction between the definer, the context 
and that being defined (Penfold and Walker, 1983, p. 41). 
As mentioned in Chapter Two, researchers argue that "women have higher rates 
of depression and anxiety than men" while "men have higher rates ... of substance abuse 
and antisocial behaviours" (Rosenfield 1999, p. 353). Of the 21 ads for pharmaceutical 
products, three were for different depression medications and two for bipolar medication, 
while all of them referred to women as the patient. Thus, these advertisements associate 
mood disorders specifically with women. 
Advertisements create anxiety around readers' inadequacies or faults. This creates 
questions about what is normal and abnormal in order to sell the product, which will cure 
the shortfalls (Metzl, 2003, p. 132). According to Penfold and Walker, "there are notions 
that are generally held and taken for granted of what is or is not "normal" in human 
activities" (1983, p. 36). Friedan argues that normality is "the highest excellence of which 
we are capable" (1974, 310). One's "highest excellence," however, is dependent on "the 
cultural norms, society'S expectations and values, professional biases, individual 
differences, and the political climate of the time" (Penfold & Walker, 1983, p. 38). The 
pharmaceutical drug ads analyzed in this study normalize "patienthood" and promote 
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medicalization by drawing upon discourses around particular ways of looking, thinking, 
and acting. Some ads also reflect what was discussed in Chapter Two about normalizing 
illnesses in an attempt to de-stigmatize the medicalization process. 
Prescription medication ads in 0 Magazine that use discourses around improving 
women's physical appearance and mood capitalize from creating such anxiety. For 
example, as much as a visible wedding ring in a pharmaceutical drug ad can use 
discourses around traditional gender roles, the absence of a wedding ring also draws upon 
gender role stereotypes and ideas of what is "normal" to promote medicalization. Of the 
12 advertisements where a wedding ring is not clearly visible, two are about improying 
physical appearance (see figures A.I 0 and A.Il) and five are about improving mood (see 
figures A.12, A.13, A.I and A.6, A.14). In one of the ads for BOTOX cosmetic (Figure 
A.I I), two middle-aged women are pictured smiling as if posed for a photograph at a 
restaurant while holding up their menus which read "I've waited long enough" and "This 
is my time." Both women's left hands are visible but no wedding rings are present. There 
is a discourse here around single women needing to improve their appearance. Janet 
Walker notes in her book Couching Resistance that often "the appropriate role for women 
involves an appropriate physical appearance" (Walker, 1993, p. 31). The presentation of 
single women aspiring for a more youthful look illustrates that women are expected to 
look appealing in order to acquire a relationship. Gautlett argues that advertisements 
often reflect "the old-fashioned idea that if women manage to be sufficiently lovely and 
fragrant, then they will be fortunate enough to have a man come along and sweep them 
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off their feet" (2002, p. 190).8 The goal implied in this ad, rather than becoming a better 
wife, is to attract the right man, and improving the way you look through BOTOX 
Cosmetic is the way to do it. Also significant in the advertisement is the relative 
appearance and age of the women in it. Both women are attractive and appear to be in 
their 30s, but the signs they are holding up imply that they have not yet received BOTOX 
treatment. Thus, the advertisement is using discourses around appearance to suggest to an 
even younger market of women that it might be their time to see their doctors in hopes of 
looking younger still. 
One of the advertisements for depression medication also illustrates Metzl ' s 
argument that advertisements create anxiety by showing an inadequacy and then a 
product that resolves the state of tension, but in this case the focus shifts from improving 
your looks to improving your mood. In a two-page advertisement which appeared in the 
April 2006 issue of 0 Magazine, two pictures construct a visual narrative of a woman 
"caught in the cycle of depression" (see Figure A.I). On the first page is a picture of the 
woman before medication (with depression) and the second page has a picture of her after 
medication. In the 'before' picture, the woman is slouched over her desk at work with one 
hand held up to her head. She appears forlorn. The caption over the second picture reads 
"break the cycle with EFFEXOR XR" and here the woman appears to have done just that 
as she is now smiling and cheerful. Depression, it is implied, is disrupting her from living 
a successful life as a working woman. It can also be concluded that the woman's job is 
the cause of her depression. With either interpretation, EFFEXOR XR can change that by 
"breaking the cycle." In this ad, social and cultural tensions and anxieties are used to sell 
8 There are heterosexual assumptions behind the ads, however, this makes sense as the demographic aim of 
o Magazine readership is heterosexual women (omediakit, facts, 2008). 
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the product. In order to remain an ambitious working woman, both inside and outside of 
the home, it is implied that one might need some assistance through medication. Or, in 
order to be content in a dead- end job, one needs to take medication. 
Many other advertisements in 0 Magazine were replete with discourses around 
'normal' physical appearance and mood. For instance, textual and visual discourses that 
mimic the self-critical voice that often plague women were found . Slogans like "Still 
caught in the cycle of depression?" (Figure AI), "You had early stage breast cancer. You 
completed Tamoxifen. Now what?" (Figure AIS), and "Does your Child ' s asthma 
medicine fit your child?" (Figure A8), promote anxiety in an attempt to make readers ask 
themselves: "have I done enough?" 
In addition to using normative discourses around appearance and mood in order to 
sell their product, some ads normalize patienthood and treatment in an attempt to de-
stigmatize and support the medicalization process. An advertisement for bipolar disorder 
illustrates this point. The first page of the three-page spread in the July issue of 0 
Magazine features a woman staring into a mirror. She appears desperate, as if she is 
looking to the mirror for answers. The caption warns "Sometimes there is another side to 
depression." The second page has a series of pictures of the woman's erratic behaviours: 
"Talking too fast," "Sleeping less," "Buying things you don ' t need" and "Spending out of 
control. " The caption below the pictures suggests "It could be bipolar disorder." The last 
page of the advertisement features a set of questions for readers to answer which will help 
them talk to their doctor about whether they are suffering from depression or bipolar 
disorder. Just below this questionnaire, readers are referred to the website 
www.isitreallydepression.com. When you visit the website, and click to "learn more 
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about a treatment for bipolar," you are led to another website for the prescription drug 
Seroquel. The fact that Seroquel is not directly associated with bipolar disorder in the 
advertisement itself is significant because it normalizes the illness first. Here the 
pharmaceutical company AstraZeneca is attempting to show that "Racing thoughts," 
"Flying off the handle," getting less sleep and compulsive spending are no longer a part 
of a normal life. Instead, they are symptoms of a psychiatric condition with a 
pharmacological solution. This type of ad encourages readers to consider themselves as 
possibly mentally ill. The ad is not just selling a drug, but the disease that goes along with 
it. As noted earlier in Chapter Two, advertising of this kind turns ordinary behaviours 
into symptoms, which make seeking medical assistance appear norn1al, if not essential. 
In addition to using anxiety to normalize the consumption of medication while de-
normalizing average appearance and everyday behaviours, the advertisements also use 
fear about the illnesses associated with the prescription drugs they are promoting. For 
instance, patients are often pictured either looking depressed , in distress, or in some sort 
of pain from the ailment the drug is being advertised to treat (see Figures AA, A.l , A.16, 
A.14, A. 7 and A.17). A sense of fear is communicated around being in the same physical 
or emotional pain pictured in the ads, and the harm you can cause yourself and your 
relationships if you do not seek treatment. Using prescription drugs to treat minor 
symptoms before they worsen, for instance, is the message in an advertisement for Zoloft 
(Figure AA). The first line of the smaller print at the bottom of the ad reads: "Depression 
is a serious medical condition, which can lead to the risk of suicidal thoughts and 
behavior." This communicates a sense of fear to encourage help-seeking. Readers are 
warned that their symptoms could worsen and lead to death if they wait. To avoid this 
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problem, however, readers are told in every ad "to ask" or "talk to" their doctor about 
medication, in this case Zoloft. Here fear is used to normalize patienthood. 
Pharmaceutical companies use discourses around existing cultural fixations to 
communicate anxiety and fear in order to promote their chemical solution. 
Autonomy and Responsibilization Discourses 
Many of the studies conducted on discourses in pharmaceutical drug 
advertisements focus on advertisements from medical journals, study the discourses in 
historical advertisements or seek to explore gender representations in a variety of 
advertisements from multiple magazines. Metzl's study focuses on women ' s traditional 
roles and how women's "madness" is seen as being caused by the absence of a man. 
Although these discourses still exist today, and it has been shown that they are reflected 
in some of the direct-to-consumer advertisements in 0 Magazine, pharmaceutical drug 
companies do not deny the advancement of women ' s place in society and the changes in 
gender roles brought about by feminist movements throughout the years. Many ads 
portray women as more independent than they were a half-century ago. According to 
Metzl , "the women ' s movement had fundamentally changed conditions for many 
women" (2003, p . 152), helping them become more independent. Throughout the 1990s 
for example, more women began seeking corporate and professional employment. Today 
many women have successfully gained a place for themselves, by themselves, and 
outside of the home. These societal shifts are reflected in the discourses present in the 
advertisements examined. 
In a partial recognition of these societal shifts a minority of the advertisements 
used in this study focus on portraying women as confident, self-assured, unafraid to ask 
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for help and able to recognize that conditions are not always shameful. This is done in an 
attempt to help modern women identify with the women in the ads. An advertisement for 
Lunesta (Figure A.2), for example, a sleep aid medication, shows a picture of a young 
woman in bed enjoying a "peaceful, restful sleep." The caption states: "Discover Lunesta, 
a sleep aid that can change your nights." The image uses a different discourse than what 
was discussed earlier around gender stereotypes and illness. It provides a narrative of 
what Metzl states is of "treatment rather than of illness or of follow-up rather than of 
diagnosis" (2003 , p. 153). The woman no longer has symptoms, unlike the women in the 
ads for Imitrex and Relpax discussed earlier. More important, however, is the fact that 
while the woman in the advertisement enjoys her "restful sleep," she also seems free from 
the pressures of "momism, men or misogyny" found in many other ads (Metzl , 2003, p. 
153). For instance, the woman does not appear to be constrained by a relationship or a 
family. Only her right hand is visible and there does not appear to be anyone in the bed 
with her. In fact, the woman is sleeping between the two pillows of a non-single bed, a 
clear sign that no-one is missing, or that she is not expecting someone to join her later. 
This woman, it seems, has chosen to seek medication for sleep in order to rest well and 
become more productive for herself, most likely in the working world. 
In another ad for Plavix (a pill that supposedly provides protection against a future 
heart attack or stroke), readers are introduced to Janice. Janice is hard-working, African 
American,9 and middle-aged . We are told she is a "formidable woman" who is in charge 
of "4000 students and staff." Janice also does not fit into the category of the traditional , 
normative woman patient as discussed earlier. Instead, she is an intelligent, well-educated 
9 Race and affluence is important as 0 Magazine aims at reaching more affluent African American woman 
than any other magazine (omediakit, facts , 2008). 
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career woman. After the Great Depression, a woman getting a career meant more than 
just a job, "it seemed to mean doing something, being somebody yourself, not just 
existing in and through others" (Freidan, 1974). Janice's left hand is clearly shown 
without a ring. Is Janice so formidable that she cannot find a mate? Or does she not need 
one because she is content on her own? There are two possible contradictory discourses 
at play here. The readers are left again to come to their own conclusion. Both 
interpretations, however, promote the use of medication to readers. The ad also tells us 
that Janice "was no match for something smaller than the point of a pencil - A CLOT" 
(see Figure A.18). Being "no match" for a clot insinuates that there is a competition of 
some sort taking place within Janice. She wants to be in control, but she has to submit to 
her weaknesses at some point and face the fact that she might need the help of 
medication. This type of dependency discourse intersects with the gender discourses 
around needing a man. According to Janet Walker, "the working woman in women's 
service jobs such as secretary or teacher, and the promise that with drug therapy she will 
better carry out her appropriate role may all be found" (1993, p. 29). As noted earlier, 
"advertisements .... are texts that profit by ambiguity" (Metzl, 2003, p. 143). The ad can 
be read equally both ways: that Janice can be empowered and have control or that Janice 
needs to submit to medication in order to remain in charge at work. Clearly, such an ad is 
likely to be successful due to the fact that it is able to connect the tensions around gender 
and gender role stereotypes that are present today with medication. 
Many other examples reflect these discourses around the independent, 
autonomous patient. An ad in the January issue of 0 Magazine for Imitrex (a migraine 
medication), tells the reader to "Get back to your life with Imitrex." This ad appears to 
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give the reader the power to get help and get back to her life routines. However, as 
discussed in Chapter Two, although there is a discourse around choice and control over 
the situation, the advertisers are associating that "choice" with a particular medication. In 
a sense, the reader's choice has already been made for them by the advertisement. The 
discourse in the ads provides an illusion of autonomy and control, but real control and 
independence can only be achieved with medication. This will be discussed further in 
Chapter Five. 
The discourse around autonomy in some of the advertisements in 0 Magazine, 
lead to discourses around power and responsibility. Many of the direct-to-consumer 
advertisements analyzed in this study ask readers to think like doctors when viewing the 
image, to "recognize the presence of [ an illness] and to construct a diagnostic narrative 
that leads to the conclusion that the object of their gaze requires treatment with a specific 
brand of medication" (Metzl, 2003, p. 148). It communicates a discourse around power 
relations by including the patient in the diagnostic process in a new way. In the past, the 
doctor always had the knowledge and power over the patient. Now, with direct-to-
consumer drug ads in popular magazines like 0, patients are fed the "facts" directly and 
led to believe that they know what is best for their ailment. An advertisement for bipolar 
disorder illustrates this point. This three-page ad featured in the January issue of 0 
Magazine identifies with the reader by stating "where you ' ve been" with "mood swings 
and relapses," and discusses "where you want to go" with "treatment to help stabilize 
your mood swings." Just below these explanations is a paragraph on "how to get there" 
with prescription ABILIFY and a brief overview of how ABILIFY is thought to work 
(see Figure A.12). Once educated about bipolar disorder and prescription ABILIFY to 
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treat it , the readers become responsibilized to change their situation if this matches what 
they or someone they know suffers from. Readers are told to "ask your doctor or 
healthcare professional if ABlLlFY is right for you." Discourses around responsible 
patients who get the facts and ask their doctor are then communicated. This type of ad 
implies that when you read up on an illness and its medication in a magazine ad, you are 
more educated about it and when you ask your doctor, you are in control. However, 
Moynihan and Cassels argue that advertising "has got nothing to do with the public's 
education" (2003, p. 106). Direct-to-consumer advertisements such as this one, by their 
very nature as advertisements have one goal in mind: to sell a product. 
There are many other ads that contain this discourse around the patient being in 
control and responsible. All of the 21 advertisements in this study refer to asking or 
talking more to your doctor. For example, an advertisement for Zelnorm, a medication for 
chronic constipation, says "relief can start by asking." Moreover, two advertisements 
analyzed in this study were for children's medication. Both ads are in the October issue 
of 0 1°. The first is for Pulmicort Respules which is an asthma medication made especially 
for children; the other ad is for Daytrana, "the first and only patch for ADHD" in 
children. Both ads suggest that readers "ask" or "talk" to their doctors about the 
medication for their child. In these last two cases however, children are featured as the 
patients but readers are likely to be concerned parents. Parents here have a dual role to 
educate themselves about their own health as well as their children and be responsible for 
taking proper care of both. 
10 October is back to school season and issues ofhealth/wellness weigh heavily on parents minds at this 
time of year. 
68 
Many of the pharmaceutical drug advertisements found in issues of 0 Magazine 
used in this study center around a discourse of helping readers be independent, feel 
worthy and take control with the use of medication for different ai Iments. One 
advertisement for Effexor (an anti-depressant drug) in the April issue of 0 reads: 
"EFFEXOR XR, The change you deserve." Another advertisement in the same issue is 
for BOTOX Cosmetic. It features a happy thirty-something woman holding a sign that 
reads: "I did it for me." While these ads may appear at first glance to be empowering of 
readers, a solid sense of self-worth, although arguably essential for living a healthy life, 
cannot be found in a prescription. Self-worth is unattainable through any synthetic 
substance. It requires more than a "quick fix." According to Starr, "[self-confidence] 
springs from self awareness and discipline. It ' s about understanding your limitations and 
making the effort to rise above them" (1999). These advertisements communicate a 
discourse that says that prescription medication is more than a simple product, it is a 
healer of low self-esteem. Some of the implications of such discourses will be discussed 
in the next Chapter. 
Conclusion 
While analyzing the discourses in pharmaceutical drug ads in 0 Magazine , it was 
important to remember the main purpose of advertising: to sell a product. It has been 
shown that the ads in 0 Magazine attempt to do this through the readers' identification 
with the women in the ads, whether it is on a physical , emotional or psychological level. 
This type of advertising tells a story about femininity - it models and idealizes certain 
roles and behaviours. The power of the discourses coming from the images and texts in 
the ads is due to the fact that women are not confident about their current identities. 
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William O'Barr argues "representations of gender in advertisements provide powerful 
models of behavior to emulate or react against" (2006). These discourses aim to 
communicate a need and desire for medication because "women are so unsure of who 
they should be that they look to this glossy public image to decide every detail of their 
lives" (Freidan, 1974, p. 72). If pharmaceutical companies can create ads that readers can 
relate to and reiterate a need for medications through these discourses, they will likely 
sell their product. 
While it is important to discuss the discourses within the advertisements, this 
analysis also includes situating the ads within the context of 0 Magazine specifically. 
Data Analysis Part Two - Contradictory Messages: An Analysis of 0 Magazine 
Practices 
Through analyzing the juxtapositions of articles and pharmaceutical drug ads in 
four issues of 0 Magazine , contradictions were found between the articles, the ads and 
statements made by the magazine. I also looked at juxtapositions in racial representation. 
o Magazine ' s positioning statement reads: "[ 0 Magazine] addresses every aspect of a 
woman's life - the material, the intellectual and the emotional" (omediakit, edit, 2008). 
Yet an analysis of the magazine shows that it seems to focus more on the material aspects 
of a woman 's life than on the emotional or intellectual aspects. A look at the 
advertisements in 0 Magazine supports the idea that the focus is on commodification. For 
instance, there are almost 500 advertisements (for clothes, food & drink, cosmetics, 
promotions, accessories, charities, home life, automotive, travel, pharmaceuticals and 
other ads) in only four issues of 0 Magazine, which averages to over 100 pages of 
advertisements per issue. 
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Table 4.1: Monthly topic, pharmaceutical ailments advertised, and context of each 
pharmaceutical advertisement in 0 Magazine. 
Issue Focus/Topic Ailments Advertised with Situating ads in context of 
of the month Drugs month 
January Happiness -bipolar disorder Winter, can be dreary, 
-breast cancer prevention lonely 
-depression 
-mIgraIne 
April Beauty -sleep apnea In spring people start to 
-allergies (x2) talk/worry about allergies 
-wrinkles 
-breast cancer prevention Asthma flares up in the 
-depression (x2) humid summer months 
-mIgraIne 
-blood clot prevention 
-asthma 
July Getting in -bipolar Bloating is not pleasant in 
touch with -mlgrame "swim suit season" 
your feelings -abdominal discomfort, 
through bloating and constipation 
reading books -depression 
-bipolar disorder 
October Beauty and -children's asthma Back to school season, 
agIng -wrinkles issues with children's 
-ADHD healthlwellness weigh 
-sleep apnea heavily on parents minds 
More contradictions were found in 0 Magazine's vision and position statements. 
While flipping through the pages of 0 Magazine to search for pharmaceutical drug 
advertisements, I began to wonder: what exactly is 0 Magazine all about? The founder of 
0 , Magazine, Oprah Winfrey, writes: "0, The Oprah Magazine is a catalyst that helps 
confident, intelligent, affluent women live their best life" (omediakit, edit, 2008). While 
this is, at first read, an inspiring position for a women ' s magazine, an in-depth analysis 
discovered that the "help" Oprah is referring to is not that easy to decipher. While gaining 
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an understanding of the discourses in the pharmaceutical advertisements in 0 Magazine , I 
found contradictions between the messages in some of the articles written for 0 
Magazine and the discourses emerging from the pharmaceutical drug advertisements 
throughout the magazine (see Table 4.1). Different messages are sent to the reader about 
what kind of help to seek in order for women to "live their best life." 
Juxtapositions of Articles and Pharmaceutical Ads in Each Issue of 0 Magazine 
In the January 2006 issue of 0 Magazine , contradictory messages around 
happiness and how to be happy can be found. Oprah ' s "here we go 0 " section (a section 
in her magazine where Oprah summarizes what lies ahead for each month ' s issue) is 
about" 11 women who are doing work that gratifies, exhilarates and makes them really 
happy. " Oprah talks about wanting to motivate women for the New Year ahead with this 
issue. With this month's focus on happiness, Dr. Phil has a section on "sparkling, self 
assured women," and talks about how to be someone everyone wants to be around by 
falling in love with yourself. Also, there is a small section on mindfulness that suggests: 
mindfulness teaches us to notice our thoughts, feelings and bodily sensations 
without immediately categorizing them as good or bad. We learn to be more 
compassionate toward ourselves, responding to our thoughts and feelings as a 
friend might, rather than as a slave to a master. Rather than be overwhelmed or 
ruled by our feelings , we become better able to choose how we want to feel and 
act in difficult situations (January, 2006, p. 38) 
These pieces of advice related to happiness come before an advertisement for Abilify, 
used to assist anyone suffering from bipolar disorder. In this advertisement, the woman is 
not able to face forward , to face life (see Figure A.12). She definitely lacks confidence, 
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self-assurance and happiness. Abilify is recommended to help stabilize mood swings, 
rather than getting in touch with your personal truth as Dr. Phil suggests or becoming 
more present to your own feelings. 
The January issue of 0 Magazine also has a section called "0 to go." Here you 
can find small cards you can rip out and keep. This month's "0 to go" consists of smart 
cards that you can tape inside your medicine cabinet as a guide to what works for what 
when you are in pain. These cards contain remedies for everything from localized aches 
and pains to intolerable, recurring pain. 0 Magazine is quick to note that the remedies for 
chronic or acute pain are not "killer painkillers like Vioxx and Bextra." Instead, "0 to go" 
suggests CELEBREX, "an anti-inflammatory in the same category as Vioxx and 
Bextra ... but Celebrex remains available because it appears to hold more potential for 
benefit than risk for certain patients." The cards also suggest topical creams and over-the-
counter (OTC) pain relievers for mild aches and pains such as a headache. Most of the 
remedies suggested are the opposite of what the pharmaceutical ads are pushing: 
prescription drugs. These "0 to go" cards come before the IMITREX advertisement for a 
prescription drug for migraines. For tension headaches, "0 to go" suggests you first 
consult your doctor. Only OTC medications are suggested (such as acetaminophen, 
aspirin, ibuprofen and naproxen sodium). Prescription drugs are only suggested for 
chronic and intolerable, recurring pain, and it is noted up front that side effects may 
occur. Suggestions are made about who should and should not consider taking certain 
drugs. On these smart cards, it is easy to read the side effects and contraindications, 
unlike pharmaceutical advertisements where this important information is placed in 
smaller print, usually on a separate page. Mixed messages are sent to readers of 0 
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Magazine about what kind of help to seek when in pain; pharmaceutical drugs are 
suggested through advertisements while over-the-counter medication is suggested by 0 
Magazine writers . 
Another example of contradictory messages about what kind of help to seek in 
order to "live your best life" can be found in an article on guided imagery (p. 158, 
January 2006). This article claims: "inside everyone (and that includes you), there's a 
brilliant coach who ' ll help you solve all your problems, kick depression, ditch anxiety, 
manage deadlines, fight off flu, and even recover faster from surgery." Rather than 
prescription drugs, this article suggests using guided imagery for numerous health 
conditions and personal issues "from easing headaches, to losing weight, to coping with 
grief to speeding recovery from sports injuries." The four pharmaceutical advertisements 
that precede this article offer medication as the first and only solution for bipolar disorder 
(Figure A.12), breast cancer (Figure A.lS), depression (Figure A.13) and migraine relief 
(Figure A.4). Guided imagery claims that people know themselves better than any expert 
would. It gives people the power to help themselves first, before seeking expert advice. 
This article on guided imagery quotes David Bresler, Ph.D, a clinical health psychologist 
and president of the Los Angeles-based Academy for Guided Imagery, as saying: "when 
you rely only on pills and procedures, you just pave over symptoms - and shoot the 
messenger." Although this article does mention "if you want to delve more deeply into a 
medical or emotional issue, you have another choice - to work with your personal 
practitioner," the messages being sent to readers around dealing with health, illness and 
healing in this issue of 0 Magazine are quite different from pharmaceutical drug 
advertisements. 
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In the July issue of 0 Magazine , contradictory messages around dealing with 
one ' s feelings can be seen . This month ' s "here we go 0 " is about books and literature. 
Oprah tells readers to live, laugh, take a chance and become enlightened through books. 
She offers books as a way to help her readers feel different emotions. This issue also has 
articles on how to deal with different feelings, from letting go of personal tragedies and 
being in the present moment to dealing with pain and other demons through talking to 
friends and facing your problems. Yet in this issue of 0 Magazine there are two ads for 
bipolar disorder, and one ad for depression - which are mental illnesses affecting a 
person's mood and emotions. The articles in 0 Magazine suggest dealing with feelings 
through reading a good book or talking to someone while the phannaceutical 
advertisements suggest dealing with difficult feelings through medication. 
In both the April and October 2006 issues of 0 Magazine, ideological 
inconsistencies around beauty were found . In her "here we go 0 " introduction for April , 
Oprah writes: "I believe there ' s beauty in you." In October, "here we go 0 " is also about 
beauty with a more specific focus on the link between beauty and aging. Here Oprah 
focuses on how time brings wisdom and understanding: "forget about how old you are. 
The real question is: how old do you feel ?" The April issue of 0 Magazine features 
sixteen articles focusing on inner beauty. An article by Anne Lamott (p. 259) titled " love 
me, love my imperfections," states: "this culture ' s obsession with beauty is a crazy, sick, 
losing game, for both women and men .. . " (p . 260). Valerie Monroe, 0 Magazine 's 
beauty director, writes: "inner beauty, unlike physical beauty, which grabs the spotlight 
for itself, inner beauty shines in everyone, catching them, holding them in its embrace, 
making them more beautiful too" (p. 256). While April's issue is focused on the 
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importance of finding your inner beauty, an advertisement for Botox Cosmetic can be 
found prior to these articles (p. ] 68). Here we see the double message: to find your inner 
beauty and also to be hyper-concerned about your outer beauty and appearance. 
Similar to the April issue of 0, Magazine, October's issue features much advice 
and guidance about accepting your own personal beauty. An article on aging features a 
quote: "instead of denying age, trying to hide it, or getting all gloomy and depressed 
about it, we might as well get good at it" (pp. 300-301), while another article gives 
readers advice on "how to live happily ever after with the person you turned out to be" (p. 
312). Another article on aging talks about Botox (p. 158): "that is why I balked in horror 
when myoId friend suggested I color my hair. In my mind, that was one step on a 
slippery slope into beauty obsession. What would be next? Botox injections? 
Liposuction? A tummy tuck?" These articles attempt to steer readers towards self-
acceptance no matter what imperfections they might think they have. 
Another section of this issue includes a 16-page guide to staying healthy and 
strong as you age, without medication. One article refers specifically to stress (p. 196): 
"can stress really age you?" The answer is yes, "stress can age our cells by ten years or 
more." Their suggestions for interventions to prevent this aging are "meditation, yoga, 
exercise, the support of friends and family, and seeing the glass half full can halt and 
perhaps even reverse the process." Bruce McEwen, Ph.D., Director of the 
neuroendocrinology laboratory at Rockefeller University in New York City, says 
"Americans have been so focused on finding that magic bullet, the quick fix, the 
pharmacological treatment to slow aging ... we don't realize there's a lot we can do to help 
ourselves." An article featuring a decade by decade guide to exercise states: "if there's a 
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magic pill for staying youthful, it may be one that's hard to swallow: exercise" (p. 200). 
After all of this good advice on accepting the way you look and exercising to stay 
healthy, the page following this 16-page spread is an advertisement for Botox Cosmetic-
the exact quick fix Bruce McEwen is referring to. The ad for Botox sends a message that 
is the opposite of what this issue of 0 Magazine is said to be about - finding beauty in 
the way you are and preventing aging without medication or invasive surgeries. 
Another example of contradictory messages sent to readers can be found in an 
article in the October "bodywise" section promoting Yoga for insomnia: "One solution 
[to insomnia] is to reach for a pill. In fact , the number of adults ages 20-44 using 
prescription sleeping medications doubled between 2000 and 2004, reports Medco Health 
Solutions, a large pharmaceutical benefits manager." This article goes on to note that "the 
drugs are generally not recommended for long-term use, and many people aren't 
comfortable taking them. For those who can't sleep, a growing body of research suggests 
that an alternative treatment is surprisingly effective: yoga." Yoga classes devoted to 
combating insomnia with breathing, meditation, chanting, and poses are suggested as 
being in opposition to medication: "drugs are a quick fix, but they don't treat the 
underlying issues that keep people up at night" (p. 152). Preceding this article (p. 141) is 
an advertisement for Lunesta, a sleep aid (Figure A.2). 
There are other articles in 0 Magazine that are not in support of medicalization, 
but instead suggest alternatives to medication. The April 2006 issue (p. 149) features an 
article titled "Anti-Cancer Herb? Could Ginkgo Prevent Ovarian Cancer?" This article 
also notes that preliminary studies show ginkgo biloba may lower the risk of developing 
ovarian cancer. An ad for Arimidex, to prevent breast cancer, is featured in the same 
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Issue (pp. 199-200). Last, a type of journaling exercise appears in most issues of 0 
Magazine (January, April and October) in a section called "Something to think about". In 
the October issue, (p. 117) the journal exercise suggests readers consider: "have you 
exceeded the expectations you had as a young adult? Where would you like to make 
changes?" This section seems to be used as a way to help readers focus on a different way 
to grow/change other than taking medication. Indeed, 0 Magazine is a magazine that 
prides itself on being founded on personal growth. In fact, 21.5% of the magazine is 
devoted to personal growth making 0 the highest % of any women ' s magazine for 
personal growth (omediakit, edit, 2008). 
Juxtapositions in Racial Representations 
Another way pharmaceutical advertisements in 0 Magazine contradict the content 
is through racial representation. 0 Magazine often focuses on highlighting non-white 
people in the content, while the pharmaceutical drug advertisements used for this study 
have little representation of various races. According to Richard Dyer, author of White , 
"research - into books, museums, the press, advertising, films, television, software -
repeatedly shows that in Western representation whites are overwhelmingly and 
disproportionately predominant, have the central and elaborated roles and above all are 
placed as the norm, the ordinary, the standard" (1997, p. 3). Although there is an under-
representation of non-white women in the pharmaceutical drug advertisements used in 
this analysis, 0 Magazine claims it reaches more African American readers than other 
magazines such as Glamour, In Style and Martha Stewart Living (omediakit, facts , 2008). 
Yet within 0 Magazine pharmaceutical drug ads, whiteness still maintains a central 
place, and continues to stand for the "normal" woman. For instance, there are only two 
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advertisements out of the 21 found in four issues of 0 Magazine in 2006 that represent 
non-white women (see Figures A.18 and A.7). 
Yet 0 Magazine prides itself on "delivering more African American readers" than 
other magazines. In order to do this, 0 Magazine's articles and stories feature many non-
white success stories. For instance, in the January 2006 issue, Actor Terrance Howard (p. 
35), a successful African American actor is featured along with the success story of two 
African American sisters who started a hair salon business, and a seven-page spring 
fashion line with a non-white model (pp. 150-157). Although in general "Whites are 
everywhere in representation," especially in the majority of phannaceutical 
advertisements used for this study (Dyer, 1997, p. 3), Oprah seems to be trying to 
counteract this norm with an extra focus on the successes of non-white individuals . In the 
April issue of 0 (p. 251), an article states: "What's wrong is to think that beauty has one 
narrow, unforgiving definition. As the multiracial men, women and families profiled in 
"mix it up!" ... reminded us, beauty is in the blend." The article goes on to note: "it's a 
gorgeous new world out there, where an infinite variety of skin tones, hair textures, and 
features harmonize and surprise." Furthermore, this article talks about the modeling 
market and how it has "opened up tremendously to make space for a new definition of 
beauty." Similarly to the January issue, the April issue features an eight-page Summer 
fashion line with a non-white model (pp. 282-289). The April issue also features a non-
white up-and-coming actress, an interview with non-white nutritionist and an article on 
Phylicia Rashad (the actress who played Clair Huxtable on The Cosby show). 0 
Magazine's July issue talks about a tribute to Tina Turner, Kelly Rowland's favourite 
music (fonner member of Destiny's Child) and author Toni Morrison - all successful 
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non-white women. Again , we see that pharmaceutical advertisements in 0 Magazine do 
not follow the lead of the content. 
Why Do the Contradictions Between the Ads and the Content Matter? 
Jones, author of The Ultimate Secrets of Advertising, offers his advice for 
successful advertising: "the advertisers address viewers as their equals and do not talk 
down to them. They respect the public ' s intelligence" (2002, p. 34). This piece of advice 
is exactly what 0 Magazine claims to do "[0 Magazine] inspires women, challenges 
them and never talks down to them ." It is no wonder 0 Magazine has a lot of advertisers, 
as they have apparently similar goals . But while advertisers and 0 Magazine take the 
stance to not talk down to their readers, they nevertheless do embody certain 
contradictions. 0 Magazine does not appear to be completely committed to personal 
growth as noted in its positioning statement. 0 Magazine 's founder's statement says this 
magazine is an opportunity "to help women see every experience and challenge as an 
opportunity to grow and discover their best self. To convince women that the real goal is 
becoming more of who they really are. To embrace their life." As this analysis has 
shown, 0 Magazine has many articles dedicated to encouraging women to do just that: 
grow and discover their best self. However, 0 Magazine has also made a decision to 
accept pharmaceutical drug advertisements that send a completely different message 
about help-seeking and self-worth. Thus, 0 Magazine editors have made a deliberate 
decision to support their glossy production value through accepting ads which send 
readers many different messages than those included in their articles . 
These contradictory messages would not be acceptable unless both the 
pharmaceutical companies placing the ads and 0 Magazine both benefited from the 
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arrangement. What would pharmaceutical drug advertisements have to offer a large 
circulation magazine such as 0 Magazine? First, advertising is no longer just a by-
product of magazine publishing; it is a vital economic necessity (Hill, 2002, p. 12). 
Advertising dollars now account for a substantial part of a magazine's profit-making 
ability. In addition, pharmaceutical drug companies offer 0 Magazine advertisements that 
readers can identify with, undercutting some of the serious articles featured in the 
magazine. The mixed messages from pharmaceutical drug advertisements can make the 
serious articles in 0 Magazine much more palatable; readers do not have to take 0 
Magazine so seriously if they do not want to. The more ambiguous an advertisement, the 
better: "the more ambiguous an ad's textuality, the more likely it will create great interest 
and generate appeal" (Beasley & Danesi, p. 102). While pharmaceutical drug 
advertisements can offer variety and appeal to 0 Magazine, at the same time, 0 
Magazine is a high-placed vehicle for pharmaceutical companies. First, 0 Magazine is a 
good fit for pharmaceutical advertisers because women have long been the target 
customers for most manufacturers and distributors of consumer products (Hill, 2002, p. 
17), and 0 Magazine prides itself on being for and about women. Very little of the 
content is directed at men. Second, 0 Magazine is a beneficial medium for 
pharmaceutical companies' advertisements because it does not have a narrow interest (not 
as narrow as cars or gardens for example), and appeals to a large audience. It is a 
magazine that aims to reach women in all aspects of their lives - "the material, the 
intellectual and the emotional" at all ages and for all races. Also, 0 Magazine can be 
regarded as entertainment or what Cornelia I1ie calls "infotainment" as it is designed to 
be funny and easy going while also discussion current social, political and other 
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infonnational issues (2001) . Furthermore, Oprah, being an African American successful 
woman herself, saves pharmaceutical companies money in advertising since they do not 
need to create new ads tailored specifically to African American women (who are readers 
of 0 Magazine). Rather, non-white readers have plenty to identify with when reading 0 
Magazine as Lee Miller, Bonnie Brennen, and Brenda Edgerton-Webster point out: "the 
dominant imagery in 0 is not the advertisements or the products placed within the sparse 
editorial pages. Readers are influenced by Oprah Winfrey and what she represents 
socially and culturally" (2005, p. 5), so there is no need to make more ads geared towards 
non-white women. 
Why are the mixed messages communicated within this seemingly beneficial 
relationship problematic? Although Oprah and her magazine alone are not solely 
responsible for medicalization, supporting phannaceutical drug advertisements in a 
magazine designed to help people live their best life can create confusion about solutions 
to life problems and potentially dangerous drugs. Moreover, the placement of 
pharmaceutical drug advertisements in relation to issues/themes in the context of 0 
Magazine is problematic because it gives the ads and their discourses more legitimacy 
(see Table 4.1). Altsteil and Grow note, "the more specialized the readership, the more 
focused the advertising should be" (2006, p. 197). For instance, the placement of 
pharmaceutical ads in 0 Magazine is focused to specific readers that are already 
interested in the very problems the ads claim to help with. A woman interested in reading 
o Magazine for articles about beauty and aging, for example, is already a potential 
customer for Botox. The reality is, pharmaceutical companies "are investor-owned 
businesses, and it is their responsibility to maximize profits" (Angell, 2004, p. 154). 
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Thus, the contradictions between the discourses found in the pharmaceutical drug 
advertisements and articles in 0 Magazine discussed in this chapter appear to exist in 
order to make women consume, rather than live their best life. While this study does not 
seek to understand the exact effects of such advertisements on people, Tom Farley and 
Deborah Cohen find it important to note, "company executives aren't stupid; if the 
advertising didn't work, they would stop advertising" (2005). Moreover, Angell argues 
"if [pharmaceutical marketing] didn't help the bottom line, if all this "education" were 
just that and had no impact on sales, heads would roll in the executive suites of the drug 
companies" (Angell, 2004, pp. 153-154). In this context, we can assume the contradictory 
messages are intentional and work or pharmaceutical companies would spend their 
money elsewhere. Also, when looking at the implications of discourses in pharmaceutical 
ads in ° Magazine, it is important to consider the significance of Oprah Winfrey herself. 
These larger implications of the discourses communicated in a magazine like 0 , The 
Oprah Magazine specifically will be discussed in the next section, Chapter Five. 
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CHAPTER FIVE: THE BROADER PICTURE - CONSEQUENCES OF 
DISCOURSES USED IN DIRECT-TO-CONSUMER PRESCRIPTION 
DRUG ADS 
Introduction 
Through my own personal experiences with medicalization (as discussed in 
Chapter One) as well as talking to friends, colleagues, and family members about my 
thesis topic, it became apparent that the discourses of medicalization are widespread and 
have become a part of everyday life. Through numerous conversations, I learned that the 
decision to go on medication is rarely questioned. Often, I found myself downplaying my 
critical stance toward medicalization, the pharn1aceutical industry and DTC drug 
advertisements at social gatherings in order to avoid confrontation. My decision to 
critically analyze pharmaceutical discourses and question chemical solutions as the first 
line of defense is not the norm. Discourses of medicalization generally dominate and 
have become so pervasive that they remain relatively unnoticed. Many people I know and 
shared my views with over the years accept prescriptions as the first solution for 
problematic life circumstances. While pharmaceutical discourses are dominant in my 
personal social group, this study has also shown that discourses of medicalization are 
reinforced through prescription drug advertisements in 0 Magazine . One of the larger 
implications of this study's findings is that the discourses discussed seem to fit in with 
the larger mass advertising that contributes to medicalization. The pham1aceutical 
discourses in the drug advertisements are not targeted only to those in extreme 
circumstances, but are mass-marketed to a mass audience. The problem is not that some 
people are taking medication. The larger issue is the increase in medication use: "the 
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average number of prescriptions per person, annually, in 2000 was eleven. In 2004, it was 
twelve" (Critser, 2005, p. 2) . As discussed in Chapter Two, this is a substantial rise from 
the 1980s when direct-to-consumer drug advertising was not as pervasive. 
The previous chapter has allowed for a greater understanding of how 
pharmaceutical advertisements in 0 Magazine communicate assumptions about the 
prevalence, incidence, treatment, and overall meaning of disease through discourse. This 
chapter will focus on why discourses of traditional gender roles, normality and autonomy 
in pharmaceutical drug ads and contradictory messages around healing in 0 Magazine 
articles are potentially problematic for women specifically. It begins by reviewing Oprah 
Winfrey's power and influence in the context of a consumer society. Next, the illusion of 
autonomy built into the discourses of pharmaceutical advertisements used in this study is 
discussed. This chapter then identifies the ways in which the promotion of 
pharmaceutical drugs through discourses in the ads can be considered a form of social 
control. Last, it discusses how the discourses found in the advertisements can potentially 
contribute to the current trend in medicalization: by turning healthy people into patients. 
Each section in this chapter will discuss the broader consequences of the discourses found 
in pharmaceutical direct-to-consumer advertisements in 0 Magazine . 
Oprah: Power, Influence and Consumerism 
Oprah has such influence that she is an ideal example of those collective "big" 
cultural phenomena that sociologists of culture love to analyze because they 
reveal a society ' s mindset (Illouz, 2003, p . 3). 
The discourses found in the pharmaceutical drug ads used for this study are 
particularly problematic because they appear in 0 Magazine, a magazine founded by 
Oprah Winfrey. Oprah has been called a highly powerful brand, in and of herself (Wilf & 
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I1!ouz, 2008). A highly powerful brand, according to Eitan Wi If and Eva Illouz, is "one 
whose name, when applied to a multiplicity of objects, henceforth makes them gain 
symbolic, social and economic status by the simple social act of being extended to these 
objects" (2008, p. 72). Through her show, magazine and website, Oprah Winfrey has 
applied her name to various products and significantly influenced consumer behaviour. 
In 1996 for instance, Oprah launched her Book Club and "in the first four years of the 
Book Club, Oprah ' s books consistently averaged about fifteen weeks on the New York 
Times bestseller list" (Farr, 2005, p. 16). Every month or so for almost six years Oprah 
would choose a novel and announce her choice on her show. Cecilia Konchar Farr notes 
how all of Oprah's Book Club authors became famous (at least temporarily) and wealthy 
(Farr, 2005 , p. 19), because people rushed to purchase exactly what Oprah suggested. 
While Oprah's influence on consumerism is clear from her Book Club, "Oprah Winfrey's 
branding power is even more spectacular in her capacity to have a de-branding effect" 
(Wilf & Illouz, 2008, p. 73). For example, Jennifer Richardson notes "in January 1998 a 
conglomerate of cattle producers from Texas sued ... Oprah Winfrey for comments she 
made on her show about the safety of the U.S . beef supply" (in Harris & Watson, 2007, p. 
165). Oprah was sued because beef sales plummeted after she made those remarks and 
"the cattle-feeding industry lost an estimated 87.6 million" (Richardson in Harris and 
Watson, 2007, p. 166). Although there was no definitive proof of a cause and effect 
relationship (which led to Oprah ' s victory over the Texas cattle industry), Jennifer 
Richardson argues that this example shows "Winfrey's phenomenal power to move 
audiences with a single sentence" (in Harris & Watson, 2007, p. 165). Considering these 
and many other similar examples, 
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it is safe to characterize Oprah not only as one of the most powerful cultural icons 
currently circulating in American culture but also as having an extraordinary 
branding power, i.e., the capacity to enhance the symbolic and economic value of 
goods that her name becomes associated with (Wi If & IIlouz, 2008, p. 73) . 
Since pharmaceutical drug advertisements appear in her magazine, the discourses of 
traditional gender roles, nom1ativity and autonomy as well as the contradictory content 
around medicalization that they contain would appear to be supported by Oprah Winfrey. 
Since readers value Oprah's opinions and are influenced by them, Oprah has an ability to 
"convince others that mirroring her purchasing habits will bring them closer to her and, 
by extension, the success she presents" (Harris & Watson, 2007, p. 8). It is highly 
probable that readers of 0 Magazine believe Oprah supports these medications . 
Wilf and Illouz argue that people relate to Oprah because she shares "the 
problems that most ordinary women cope with under modem politics - weight problems, 
failing romantic relationships, lack of self-esteem" (2008, p. 75). In other words, Oprah 
shares her "failed but battling self' with her audience (Wilf & IIIouz, 2008, p. 79). Just as 
Oprah seeks to change the participants on her show, and its viewers by giving advice and 
free therapy (Illouz, 2003 , pp. 130-131), her magazine is another way to reach people 
(who perhaps do not have time to watch her show) and influence their lives. 0 Magazine 
readers "approach the publication in search of self-identity and self-awareness through 
the illusion that it is attainable through economic mobility and material wealth" (Miller, 
Brennen & Edgerton-Webster, 2005: ] 1). In other words, readers look to 0 Magazine 
with an interest in self-improvement and they are told how to do this through the articles 
and advertisements within each issue. Lee Miller, Bonnie Brennen, and Brenda Edgerton-
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Webster argue that 0, The Oprah Magazine promotes "a culture of consumption and 
excess, 0 encourages readers to fulfill themselves through conspicuous consumption" 
(2005, p. 12). However, the degree to which Oprah links the need to value oneself with 
the consumption of goods, including pharmaceutical drugs, is troublesome because she is 
so infl uential. Oprah promotes the use of pharmaceuticals just as she does other consumer 
products such as perfume, skin care products, fashion and food . This opens the door to 
normalizing chemical intervention. 
The Illusion of Autonomy 
The concept of autonomy in relation to health has held different meanings for 
different groups of scholars . For IIIich, complete autonomous healing was of great 
importance, although some have argued that his ideas were too extreme. I I Autonomous 
decision-making, according to some feminist scholars, should be self-directed. 
Experiential or embodied knowledge (knowledge developed from personal experience) or 
empathetic knowledge (knowledge gained from the experiences of other individuals) is 
considered important (Fowler & Lee, 2007; Lorentzen, 2008). Susan Sherwin notes that 
although scholars disagree on how autonomy is best achieved, "there are some common 
features to its use" (1998 , p. 21) . This section argues that individuals' rights to make up 
their own minds about the specific health services they wish to receive are being 
jeopardized by direct-to-consumer drug advertisements and the discourses they reiterate. 
The discourses in DTC ads have the potential to subvert and compromise autonomy as 
opposed to better educating consumers. Readers of magazines such as 0 Magazine are 
exposed to DTC ads which are full of stereotypical discourses that can have an effect on 
II Illich, in complete keeping with his views in Medical Nemesis , refused to treat his cancer with surgery 
(see Critser, 2005) 
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people 's perceptions about the meaning and treatments of "disease". The protection of 
patient autonomy can be undermined by clever DTC drug advertising. 
One of the ways discourses in DTC drug ads can jeopardize autonomous decision-
making is through the illusion of complete information. Caplan, whose analysis focuses 
specifically on mental illnesses, argues that "women must be allowed to choose drugs, of 
course, if they have been completely informed about the ways they work and any 
undesirable effects they can have" (2005 , p. 163). While warnings and mandatory 
information is present in each ad, it always appears on a separate page in a much smaller 
font. What readers see first is the medication, the disorder or condition it is associated 
with, or the idealized lifestyle that can be achieved by taking the drug, rather than the 
important information about potential side-effects. The problem with this is that the side-
effects of medication "may often far outweigh any possible benefit to the woman" 
(Penfold & Walker, 1983, p. 203). Moreover, while DTC ads may be perceived as having 
accurate information or knowledge about conditions and the medication listed as 
treatment, complete information about the way drugs work is not always known. An 
example is found in an ad for bipolar medication that reads (in smaller print on the 
second page of the two-page spread): "While the exact way ABlLIFY (or any medicine 
for bipolar disorder) works is unknown, it is thought that ABILIFY may work by 
affecting the activity of some key brain chemicals adjusting dopamine, instead of 
completely blocking it, and adjusting serotonin" (see Figure A.12) . While ABlLIFY is 
being promoted through this DTC ad in 0 Magazine , the actual way the medication 
works or if it will work remains uncertain. Complete information about a drug is not 
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always possible, what is possible is to know how great your life will be by taking this 
drug. 
Discourses in the DTC ads discussed in the previous chapter can also compromise 
autonomy by communicating an illusion of individual control over health. They do this 
by claiming to educate consumers when in fact they are encouraging readers to "ask" or 
"talk to" their doctor about medication. As discussed in Chapter Two, doctors often 
attend educational sessions sponsored by pharmaceutical companies where they get 
biased information about Ilew medications on the market. As a result, doctors might not 
be a source of accurate information (Moynihan & Cassels, 2005, p.24). An average 
reader of 0 Magaz;ne would not be informed about this complex relationship between 
pharmaceutical companies, doctors and potential patients. This is problematic because 
women cannot make an informed decision unless the complex relationship between 
pharmaceutical companies and doctors is shared as widely as information about the 
medications themselves. Furthennore, while individuals should have control over their 
health, each ad analyzed for this study (except Figure A. J 4) directly associates a 
particular condition or state of being with a specific prescription medication. The 
pharmaceutical industry's goal , Moynihan and Cassels say, is "to create new ideas about 
illnesses and conditions .. . [and to] make the link between the condition and your 
medicine, in order to maximize its sales" (2005, p. xiv). Thus, the goal of pharmaceutical 
advel1isements is not to educate readers so they can make autonomous decisions, but 
rather, to sell a product. 
Discourses in the DTC ads can also subvert autonomous decision-making by 
promoting individual dependence on medication without taking personal problems or life 
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circumstances into consideration. As Sherwin argues, the problem with this dependence 
is that "illness, by its very nature, tends to make patients dependent on the care and good 
will of others; in so doing, it reduces patients ' power to exercise autonomy" (1998, p. 20). 
Moreover, Caplan argues "the preoccupation with problems, weaknesses and strangeness 
works like a detour sign, streaming the traffic of clinical interpretation toward 
abnormality" rather than looking at social conditions (2005, p. 60). According to Janet 
Walker, "it would be against the interest of the drug companies to admit any possibility 
that social change is what is required to relieve some of the symptoms depicted (1993 , p. 
31). Instead, Walker argues, " the cure [drug companies] promise is individual 
behavioural and cosmetic change" (1993, p. 31). Imitrex, for example, may be prescribed 
if "migraines are disrupting your life. " With Imitrex, however, you can "get back to your 
life" (see Figure AA). Although it is never certain from the ad what is causing the 
woman ' s migraine, social problems are not suggested as part of the problem. Greg Critser 
argues "prescription drugs have become a way of delaying premature death without 
dealing with the underlying soul and body sickness of modem life and modem life 
choices" (2005, p. 253). 
Another way the discourses found in the DTC ads can jeopardize autonomy is by 
promoting adjustment to social norms and promising self-worth. The people in the 
pharmaceutical drug ads and the nature of the desirable behaviours the drugs promise to 
produce are consistent with wider social norms both past and present. As discussed in 
Chapter Four, discourses around traditional female gender roles were found to be present 
along with the more recent trend of women working in social service jobs (see Figure A.4 
and A.18) . In both examples, the goal is to encourage women to better carry out their 
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appropriate roles through drug therapy. Furthermore, quotes that appear in ads such as the 
one for Botox for example (Figures A.l 0 and A.II), seems to encourage autonomous 
decision-making, yet Botox is really about suppressing people ' s paranoia about aging and 
helping them to "adjust" to particular gender stereotypes and norms. According to 
Ratcliff, cosmetic surgery has become "not an issue of wanting a change, but needing it" 
(Ratcliff, 2002, p. 133). Erikson and Kress report that women predominate in certain 
illness categories because of an "exaggeration of socially promoted feminine 
characteristics." Sexist pressures are present in some of the DTCA used for this study to 
urge women to conform to current standards of "health" and beauty through medication. 
The illusion of autonomy is also connected to ideas of self-worth in the ads. DTC 
ads portray taking medications as something readers can do for themselves. For instance, 
the advertisement for Effexor (an anti-depression medication) states: "Effexor XR, the 
change you deserve" (Figure A.l). These slogans encourage readers to feel worthy of 
change and to take action to improve themselves. However, improving yourself using 
chemical substances sold through ads that promote traditionally gendered norms is not 
truly autonomous behaviour. 
By giving limited information in the guise of health education these ads 
undermine autonomous intent. As discussed above, the advertisements can actually limit 
autonomy and equate being a strong, self-actualized and autonomous woman with using 
pharmaceuticals to fill any void or deficiencies . Consequently, dependence on medication 
does not promote autonomy but is rather a form of chemical ' solution ' to what is often a 
complex range of social and individual problems. 
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Discourse and Social Control 
According to Peter Conrad and Joseph Schneider, "social control is usually 
conceptualized as the means by which society secures adherence to social norms; 
specifically, how it minimizes, eliminates, or normalizes deviant behaviour" (1992, p. 7). 
In other words, social control is a process by which people define and confonn to specific 
norms and values, thereby de-nom1alizing anything that deviates from this specific and 
narrow range of expectations. The discourses in the advertisements promote social 
control of behavior through medication (rather than social change) by reiterating 
traditional gender roles, promoting concepts of 'normality' and through an autonomy 
discourse which encourages a chemical 'fix' for 'symptoms' or life problems. The 
discourses in the pharmaceutical drug ads used in this study attempt to convince readers 
to use phannaceuticals as a solution to problems that prevent them from adhering to the 
norms and values of society. The "problems" discussed in Chapter Four, such as aging 
and wrinkles as well as a woman's inability to function in her traditional gender role, are 
marketed to readers as not "fitting in" with the values of society and of 0 Magazine's. 
Medication is offered as the solution. Why do pharmaceutical companies foster this 
control? According to Marcia Angell, "it helps the bottom line. It increases sales" (2004, 
p.153). 
Susan Sherwin talks about the use of the term "prevention" and the idea of "risk 
management" in medicalization techniques as ways for medical control to be taken up 
enthusiastically, without criticism (1998). Figures A.15 and A.19 are good examples of 
risk discourse where pharmaceutical companies instill fear while at the same time 
providing a solution to that fear: pharmaceuticals. Figure A.19 uses discourses around 
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risk, prevention and fear to promote readers' determination to "fight back" with slogans 
like "The opponent, breast cancer recurrence . In defense, ARIMIDEX." These 
discourses potentially create fear as well as an illusion of being in control of such an 
uncontrollable disease. Similarly, Figure A.15 states: "You had early stage breast cancer. 
You completed tamoxifen . Now what?" These types of slogans reiterate discourses 
around prevention and provide solutions for risk management and "contro!." However, 
the actual risk of breast cancer re-occurence is not known and both of these medications 
have only been effective for some women, not all women who tried them. In this case, the 
promotion of medication benefits pharmaceutical companies and the broader society by 
decreasing calls for social change in regards to rising cancer rates. Ratcliff argues that "a 
serious concern with prevention would focus our attention on a variety of environmental 
causes of cancer" (2002: 106). In contrast, the promotion of individualized chemical 
solutions attempts to increase profits for Big Pharma through prevention therapy for 
cancer. 
The Medicalizatiol1 of Everyday Life: HolV Do the Discourses Promote Medicalization? 
The discourses in the pharmaceutical drug ads promote medicalization in several 
ways . First, they do so by framing women ' s discontent as biological in nature. Erikson 
and Kress rep0l1 the view of feminist theorists that "women's anger, depression and 
discontent have been reframed as medical or psychiatric symptoms and that, as a result, 
the often difficult and distressing life circumstances of women have been disregarded" 
(2008, p. 152). Women encounter many life stressors which could be the real cause of 
many symptoms of 'diseases' and 'disorders ' found in the ads. For instance many women 
at some point in their lives devote a substantial amount of time and effort to unpaid work 
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in the home. Many studies have been conducted comparing the mental health of 
employed women to housewives. Mary Clare Lennon argues that "more symptoms 
among housewives, found in several studies, are assumed to derive from the burdensome 
and tedious nature of housework" (in Horwitz & Sheid, ] 999, p. 289). Further, women ' s 
overrepresentation in part-time and service industry jobs as well as their experience with 
poor quality jobs and unstable employment means that women's involvement in the 
labour force can also undermine their sense of competency, psychological well-being and 
health (Lennon, in Horwitz & Sheid, 1999, p. 285). This is the context in which drug 
companies use the stresses of women's traditional role to get women to think they need 
medication for things like tension headaches, mood swings and difficulty sleeping (see 
Table 5.2). The problem is that women are not given an option to have "help in dealing 
productively with the real causes of their emotional upset" (Caplan, 2005 , p. 163). 
Instead, the use of gendered stereotypes in the promotion of these medications only 
reinscribes the idea that women need individualized 'fixes ' for these problems. 
The discourses discussed in this study also promote medicalization by excluding 
non-pharmaceutical alternatives from the mix. In all the ads analyzed , the only solution 
suggested is medication. This is problematic because of the lack of concern about the 
potential consequences of using drug treatment alone. For instance, Penfold and Walker 
argue that "drug treatment may prevent the accurate diagnosis of [other] medical 
conditions" (1983, p. 202). Moreover, Caplan notes the effects of labeling: "when terms 
or images of abnormality or mental illness are spoken, images of difference and 
alienation come to mind suggesting that "they" are not as competent, human or safe to be 
around as the rest of "us'''' (2005, p. 11). In addition, according to Penfold and Walker 
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dependency on drugs can "erode many facets ofa woman's life. She can feel powerless, 
helpless, and afraid to be without her chemical crutch" (1983, p. 202). 
Table 5.2: Type of ailment advertised, number of each type found in the issues of 0 
Magazine used for this study and broader classification 
Type Number of Each Type Classification of ailment 
Migraine 3 Tension/pain 
Allergies 2 Allergies 
Depression 3 (+ I repeat, not included) Mental illness/mood disorder 
Bipolar 2 (+ I repeat, not included) Mental illness/ mood disorder 
Cancer reducer 2 Life threatening illness 
Asthma (one for adults 2 Respiratory 
and one for children) 
Sleep aid 2 Sleep 
Wrinkles 2 Beauty/physical appearance 
Blood clot prevention 1 Life threatening illness 
Attention-deficit 1 Mental illness/mood disorder 
hyperactivity Disorder 
(for children) 
Abdominal discomfort 1 Digestive 
The third way the discourses in pharmaceutical prescription drug ads promote 
medicalization is by shifting attention away from women's resources. The ads show 
women as merely victims of their fate rather than capable human beings. Women need to 
be encouraged to draw upon their resources, be they internal or external. Laura Purdy 
argues that medicalization would not be such a burden if medicine took a feminist 
approach to health care and began to see women as persons in their own right. For Purdy 
this would mean "[sensitizing] every practitioner to the way women's role can affect their 
health ... sympathetically listening to what women have to say about their problems and 
probing the context of their lives" (200 1, p. 259). 
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Conclusion 
Using CDA, this study brought to light how OTC ads in 0 Magazine reiterate 
discourses around traditional gender roles, normative behavior, and concepts of 
autonomy. It also found that these discourses are often in contradiction to the 
information, articles and stated aims of 0 Magazine. 
Within the larger sociological context, these discourses can be seen as 
problematic for women for many reasons. The discourses create an illusion of autonomy 
and individual control, while also attempting to increase medication use and 
pharmaceutical company profits . Moreover, the medicalization discourses reduce the 
potential for social change by excluding other discourses/approaches to life problems and 
are particularly potent because they are presented in a highly influential women's 
magazine with contradictory stated aims. Last, this study found the discourses promote an 
increase in the medicalization of everyday life, leading to potential harm. 
While it is unlikely that advertisers will change their strategies or Oprah will tum 
down the advertising dollars provided by pharmaceutical companies, hopefully this 
research will contribute to an increased awareness and promote debate about the impacts 
ofOTC advertising on women . For there is no doubt that a better understanding of the 
problem of medicalization and its pervasive influence on everyday life is needed. 
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Appendix 1 
rv:~f8~!x'i~~OHRC~A~ION FOR EFf EXOR XR" 
~E:;:';;,;l~!~:i::ER~~~~:';;£~"1Ii~~1>~ -
::::,~:'::'=~~:1""'""""- ' ''-~'' ~_~'''''ild ''_ 
~t~gs';[£¥l1#~~~~7::;'~f~~Tl~i'~~~ 
-. 
EFFEXOR XR, a 1~~Il/J1K)1"I '1JediCfne. 
hiI'5 't>eto,., s/ltw..'f' to h"t~) 11',;.oi1l(' SYIT.plr;lll~ 
of~.w:.n .m,l to help p l1!'lI'I'nt them 
from romiflg ~/c. 
Figure A.I: Advertisement by Wyeth Pharmaceuticals Inc. for Effexor, a prescription 
drug used to treat symptoms of depression, from 0 , The Oprah Magazine (April, 2006) 
109 
Figure A.2: Advertisement by Sepracor Inc. for Lunesta, a sleep aid prescription drug, 
from 0, The Oprah Magazine (April, 2006) 
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• VOII s!lool{llakp. Zelnorm Iwir;e ~ ~ on an t.mplv SI~il1ae~ $Il(trll)i belore 
yoIlea' a meat, <y' ~8 y1llJf tIoC!flI pr8scrille!;il. 
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~ was f>tJtp,ewi~. 00 not \I"Iftlelooti'n IO.otfle, people. _ if .t~ly ~ 
tile ~a~S~I1JPI~ms !~at .\'C)\j ~a"e. Thi.' IM!I,., som~laril!lS f~ most imp 
tmt mfomrahon about Zelrionn. fOI mOOt!nf{l(mai'~.la!k wiI~ your!ll.lt· 
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"'" 80015 
Figure A.3: Advertisement by Novartis Pharmaceuticals Corporation for Zelnorm, a 
prescription drug used to treat abdominal discomfort, from 0, The Oprah Magazine 
(July, 2006) 
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Figure A.4: Advertisement by GlaxoSmithKline for Imitrex, a prescription drug used to 
treat migraines, from 0, The Oprah Magazine (January, 2006) 
Figure A.S: Advertisement by Pfizer Inc. for Zyrtec, a prescription drug used to treat 
allergy symptoms, from 0, The Oprah Magazine (April, 2006) 
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Figure A.6: Advertisement by GlaxcoSmithKline for Wellbutrin, a prescription drug used 
to treat depression, from 0, The Oprah Magazine (April, 2006) 
A tough migraine needs 
a tough migraine mediCine. 
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Figure A.7: Advertisement by Pfizer Inc. for Relpax, a prescription drug used to treat 
migraines, from 0 , The Oprah Magazine (July, 2006) 
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Figure A.8: Advertisement by Astra Zeneca for Pulmicort Respules, a prescription drug 
used to treat asthma in children, from 0, The Oprah Magazine (October, 2006) 
~;:y,t~~: ~~::'d 1><) ~p!)!i~o1 d .. i~.I ",d"",;, dry <kifl. whi(h;, fi~ of ~"Y (ut,or i"i1aiion. s~. ;n,-,-, ~.dtatio .•.O",~,' •. ,' .', ',' ... ~,:'~, 
PIeHl SH ac!ditl~MllmmrtMt infomW:ion i$<iUt Oaytm,,~ on tile fOII~ P'O" ! ;;3IIIIU ~,. . .-
Figure A.9: Advertisement by Shire Pharmaceuticals for Daytrana, a prescription drug 
patch used to treat Attention-deficit Hyperactivity Disorder (ADHD) in children, from 0, 
The Oprah Magazine (October, 2006) 
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Figure A.I 0: Advertisement by Allergan, Inc. for Botox, a prescription drug used to 
minimize fine lines and wrinkles, from 0, The Oprah Magazine (April, 2006) 
Figure A.II: Advertisement by Allergan Inc. for Botox, a prescription drug used to 
minimize fine lines and wrinkles, from 0, The Oprah Magazine (October, 2006) 
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Figure A.12: Advertisement by Bristol-Myers Squibb and Otsuka America 
Pharmaceutical Inc. for Abilify, a prescription drug used to treat bipolar disorder, from 0, 
The Oprah Magazine (January, 2006) 
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Figure A.13: Advertisement by Pfizer for Zoloft, a prescription drug used to treat 
depression, from 0 , The Oprah Magazine (January, 2006) 
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same pei10d 01 time? 
l. HlIW much!rl a problem dkl any of tfrese sihlittlnm; r.;m~1! 
YOU (like bI!lng Ullabll! ttl work; hiMng family, JimI'IIly, (Jf legal 
~'iimYurgeHin9Info3erlOu5 argUi'mmtsorfigh"tS)? 
Nllproolen"! 
1..t;l1orprrJJlfTf. 
t·':tW'2$·'~MiJ 
i6i1rBallyliepmssionJlOm 
Figure A.14: Advertisement by Astra Zeneca Pharmaceuticals for Bipolar Disorder. The 
website lists Seroquel as the prescription drug used to treat the symptoms of Bipolar 
Disorder, from 0, The Oprah Magazine (July, 2006) 
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Figure A.15: Advertisement by Novartis Pharmaceuticals Corporation for Femara, a 
prescription drug used for the prevention of breast cancer recurrence, from 0, The Oprah 
Magazine 2006) 
I(~ 
.u~s. Pharmaceuticals 
Figure A.16: Advertisement by Pfizer Inc. for Relpax, a prescription drug used to treat 
migraines, from 0, The Oprah Magazine (April, 2006) 
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Figure A.17: Advertisement by Takeda Pharmaceuticals Company Limited for Roserem, 
a sleep aid from 0, The Oprah Magazine (October, 2006) 
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Figure A.l8: Advertisement by Sanofi-Synthelabo Inc. (a member of the sanofi-aventis 
group) and Bristol-Myers Squibb for Plavix, a prescription drug used to prevent future 
blood clots, from 0, The Oprah Magazine (April, 2006) 
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Figure A.19: Advertisement by Astra Zeneca Pharmaceuticals for Arimidex, a 
prescription drug used for the prevention of breast cancer recurrence, from 0, The Oprah 
Magazine (April, 2006) 
Figure A.20: Advertisement by MedPointe Healthcare Inc. for Astelin, a prescription 
drug used to treat allergies, from 0, The Oprah Magazine (April, 2006) 
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Figure A.21: Advertisement by GlaxcoSmithKline for Advair, a prescription drug used to 
treat asthma, from 0, The Oprah Magazine (April, 2006) 
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